Photodynamic therapy (PDT) uses the combination of nontoxic dyes and harmless visible light to produce reactive oxygen species that can kill cancer cells and infectious microorganisms. Due to the tendency of most photosensitizers (PS) to be poorly soluble and to form nonphotoactive aggregates, drug-delivery vehicles have become of high importance. The nanotechnology revolution has provided many examples of nanoscale drug-delivery platforms that have been applied to PDT. These include liposomes, lipoplexes, nanoemulsions, micelles, polymer nanoparticles (degradable and nondegradable), and silica nanoparticles. In some cases (fullerenes and quantum dots), the actual nanoparticle itself is the PS. Targeting ligands such as antibodies and peptides can be used to increase specifi city. Gold and silver nanoparticles can provide plasmonic enhancement of PDT. Two-photon excitation or optical upconversion can be used instead of one-photon excitation to increase tissue penetration at longer wavelengths. Finally, after sections on in vivo studies and nanotoxicology, we attempt to answer the title question, " can nanotechnology potentiate PDT ? "
Introduction
Photodynamic therapy (PDT) is an emerging modality for the treatment of a variety of diseases that require the killing of pathological cells (e.g., cancer cells, infectious microorganisms) or the removal of unwanted tissue (e.g., neovasculariztion in the choroid, atherosclerotic plaques in the arteries). It is based on the excitation of nontoxic photosensitizers (PS) by harmless visible light leading to the production of highly toxic reactive oxygen species (ROS) that kill cells. Suitable PS have a high extinction coeffi cient in the far-red or nearinfrared (NIR) spectral region and a high yield of the longlived triplet electronic state (formed from the excited singlet state by intersystem crossing). The triplet PS is able to react with surrounding molecular oxygen by one of two distinct pathways. The type 1 pathway involves electron transfer to or from the triplet PS that can lead to a variety of oxygen free radicals such as superoxide, hydroxyl radicals, and hydroperoxides. The type 2 pathway relies on the fact that molecular oxygen is a triplet in its ground state and therefore has a spinallowed interaction with PS triplet producing both species in the singlet state and singlet oxygen ( 1 O 2 ) is a potent oxidizing agent. Figure 1 shows a Jablonski diagram and the resulting type 1 and type 2 pathways.
For PDT to be both effective and safe, it is crucial that the PS should be delivered in therapeutic concentrations to the target cells (such as tumor cells) while simultaneously being absorbed in only small quantities by nontarget cells, thus minimizing undesirable side effects in healthy tissues. There are two main obstacles to achieving this aim: most PS have extended π -conjugation systems, making the molecules highly planar and, in addition, the molecules tend to be highly hydrophobic, and therefore, most PS form aggregates in an aqueous environment [1] . This aggregation lowers the efficiency of the PS, which must be in monomeric form to be photoactive [2] . Second, PS have generally not been found to bind or migrate preferentially to tumor cells, making it difficult to target only the diseased tissue when applying PDT [3] . Considerable efforts have therefore been directed at designing delivery systems that can incorporate PS in monomeric form without diminishing its activity and without causing any harmful effects in vivo .
Many of these delivery systems take the form of nanoparticles or other nanostructures. Indeed, lipid and detergent nanostructures (liposomes and micelles) were routinely used in PDT before nanotechnology became a separate and rapidly growing area of specialization. Several questions need to be answered in the design of nanoparticle delivery agents Initial absorption of a photon by the ground state of the singlet PS gives rise to the short-lived excited singlet state. This can lose energy by fl uorescence, internal conversion to heat, or by intersystem crossing to the long-lived triplet state. PS triplet states are effi ciently quenched by energy transfer to molecular oxygen (a triplet state) to give type 2 (singlet oxygen) or by electron transfer to oxygen or to biomolecules to give type 1 ROS (superoxide and hydroxyl radical). for PS. First, should the PS be noncovalently encapsulated in the nanoparticle or covalently attached to it ? If the PS is only noncovalently associated, it is likely to be released more easily and therefore better taken up into cells. However, the PS may be prematurely released in the serum before the nanoparticles has had a chance to accumulate in the tumor as is hypothesized to occur via the enhanced permeability and retention (EPR) effect. Second, should the nanoparticles be biodegradable or not ? If they are biodegradable, the material composition will be limited to lipids or certain polymers, whereas nonbiodegradable nanoparticles may remain in the body for long periods and this may lead to concerns of toxicity caused by the delivery vehicle and not the drug.
D E F G H I
Although the majority of nanoparticles have been used as delivery vehicles for recognized PS such as tetrapyrroles, phenothiazinium dyes, or perylenequinones (see Figure 2 for representative chemical structures of PS covered in this review). However, there are some instances when the nanoparticles themselves act as the PS in the absence of preformed PS. For this to occur, the nanoparticles themselves have to be able to absorb light by virtue of possessing an extinction coeffi cient of appreciable size in an appropriate region of the electromagnetic spectrum and to then form an excited state that can lead to some photochemical generation of ROS. Examples of these classes of nanoparticle include fullerenes, zinc oxide (ZnO), titanium dioxide (TiO 2 ), and even quantum dots (QDs).
The aim of this review is therefore to give an overview of nanostructures that have been used in the PDT fi eld and relevant examples of each class. The fi eld has grown so rapidly in recent years that it is no longer possible to compile a comprehensive review, so we will concentrate on important and recent contributions. The readers will have to excuse the diffi culties we have faced when classifying multifunctional nanoparticles. Many nanoparticles could have been covered in multiple sections (sometimes up to three or four different classifi cations) and there is no obvious rule for deciding between them. We will then try to critically answer our title question, " can nanotechnology potentiate PDT ? "
Lipid-based nanoparticles
Lipids are amphiphilic molecules with both a hydrophobic and a hydrophilic part that spontaneously assemble into ordered structures in an aqueous environment, where the amphiphiles are arranged such that the hydrophobic parts cluster together and the hydrophilic parts face the water (usually on the outside). Many lipids will spontaneously form a membrane composed of a lipid bilayer, and this fact underlies one of the basic processes in the creation of life as we know it, the formation of cells. Lipid-based nanoparticles, such as liposomes, lipoplexes, and nanoemulsions have been used extensively in recent decades as drug carrier vehicles for hydrophobic PS.
Liposomes
Liposomes are nanosized artifi cially prepared vesicles of spherical shape made from natural phospholipids and cholesterol. Liposomes were discovered in 1961 by Alec D. Bangham who was studying phospholipids and blood clotting, and since then they have become very versatile tools in biology, biochemistry, and medicine [4] . Liposomes can be fi lled with drugs and used to deliver drugs for cancer and other diseases.
Liposomes have thus far been the most intensively studied carrier system for PS [5] . Their structure is composed of phospholipids with a hydrophilic head group and two hydrophobic chains, which enables them to contain both hydrophilic and hydrophobic drugs [6] . The liposome is made up of one or more concentric phospholipid bilayers, with an aqueous phase inside and between the bilayers [7] . The bilayers also often contain cholesterol, which is used to control membrane fl uidity and increase stability, as well as for modulating membrane-protein interactions [3] . PS can be packaged into liposomes in two distinct manners depending on the lipophilicity and water solubility of the PS itself. First, water-soluble hydrophilic PS or even solid particles of PS are dissolved or suspended in the aqueous interior of the liposomes (see Figure 3 A). Second, hydrophobic non-water-soluble PS can be dissolved in the hydrophobic environment produced the fatty acid side-chains in the interior of the lipid bilayer (see Figure 3B ). Once the PS has been packaged in the liposome, it can be delivered to cells in two main ways: the liposome can fuse with cell membranes and release its contents into the cytosol or it can be taken up by phagocytic cells and then disintegrate in the endosomes or lysosomes, again releasing the active drug into the cell [8] .
Many experiments have demonstrated unequivocally that using liposomes to administer PS can substantially improve the effi cacy and safety of PDT. For example, when rats whose brains were implanted with a human glioma were treated with PDT using the PS Photofrin and the uptake into the tumor tissue was signifi cantly enhanced when the PS was delivered using liposomes [9] . Similar results have been observed with different tumor models and different PS [10] . This increased effi ciency can be partly attributed to the role of liposomes in preventing aggregation of the PS. For example, when the hydrophobic PS, hypocrellin A (HA), was packaged in liposomes, it remained in monomeric form, unlike the aggregates formed when suspended in dimethyl sulfoxide-solubilized saline [11] . Liposomal HA also achieved a higher tumorto-normal tissue ratio and higher maximal levels within the tumor cells compared with the saline suspension.
One of the most successful examples of the use of liposomal delivery vehicles has been that of Visudyne (see Figure  2A ). Visudyne is a lipid-formulated composition of benzoporphyrin derivative mono acid ring A (BPD), or verteporfi n, which is provided by (QLT Phototherapeutics, Vancouver, Canada); as a freeze-dried preparation composed of egg phosphatidyl glycerol and dimyristoyl phosphtidylcholine (BPD/EPG/DMPC; 1.05:3:5 w/w/w) [12] . Visudyne has been widely used in ophthalmology as a PS in combination with transpupillary red laser for destroying neovasculature in the eye secondary to disease such as wet age-related macular degeneration [13] . A second successful application of liposomes in PDT drug delivery was that of zinc(II) phthalocyanine (ZnPC; see Figure 2B ). ZnPC is highly insoluble and was formulated by Ciba-Geigy Pharmaceuticals in liposomes composed of palmitoyl-oleoyl-phosphatidylcholine and dioleoyl phosphatidylserine (ZnPC/OPOC/OOPS; 1:90:10 w/w/w) to form CGP55847 [14] . Although CGP55847 was tested in clinical trials of PDT for squamous cell carcinomas of the upper aerodigestive tract [15] , it never received regulatory approval.
However, such " conventional " liposomes, with no additional features, have the drawback of a short plasma half-life, of the order of minutes [16] . This is fi rst due to rapid lipid exchange between the liposomes and the lipoproteins, which leads to irreversible disintegration of the liposome. Second, conventional liposomes are easily opsonized by plasma proteins and are then quickly taken up by cells of the mononuclear phagocyte system, thus, they accumulate in mononuclear phagocytes in the liver, spleen, bone marrow, and blood circulation [3] . The resulting short circulation time of unmodifi ed liposomes makes it diffi cult to achieve elevated tumor-to-normal tissue ratios of PS. Therefore, to make liposomes tumoritropic, they must be altered in some way. There are two main ways in which liposomes can be modifi ed: passive and active targeting.
Passive targeting relies on the fact that if liposomes are allowed to circulate for a suffi ciently long time, they will naturally preferentially accumulate in tumor tissue. This is due to the fast angiogenesis in malignant tissues, which results in enhanced vascular permeability and the lack of a functional lymphatic system in tumor tissue that impedes the return of extravasated macromolecules to the central circulation [17] . To achieve this effect, liposomes have been designed with longer circulation half-lives by making them " invisible " to lipoproteins and the mononuclear phagocyte system. Longcirculating liposomes can be created by using lipids with polyethylene glycol (PEG) headgroups; such liposomes are referred to as " sterically stabilized " or Stealth ® liposomes [16, 18] . PEG is most commonly used as the polymeric steric stabilizer for liposomes, as it can be manufactured in large quantities with high purity, has low toxicity, and is nonimmunogenic and antigenic [6, 19] . One drawback of passive targeting is that Stealth ® liposomes have been demonstrated to have decreased interaction with cells, suggesting that they may be less effective than conventional liposomes in transferring PS to tumor cells [3, 20] . Further studies are needed to see if this is indeed the case.
Liposomes have also been developed with a triggered release mechanism, so that the release of the PS can be tightly controlled. Various stimuli, such as heat, light, pH, and target binding have been used as the trigger [21] . Thermosensitive liposomes are constructed using temperature-sensitive lipids or coated with thermosensitive polymers that disintegrate when their temperature increases above 42 ° C [3, 22] . pHsensitive liposomes are constructed by adding acid-sensitive molecules to the liposomal membrane and are designed to release their contents between pH 5 and 6.3 [23] . The basic principle underlying these mechanisms is the same: the liposomes are designed so that applying a " switch " will destabilize the phospholipid bilayer, thus increasing its permeability and releasing the PS contained within.
In active targeting, one or more molecules that have a high affi nity for specifi c membrane markers on malignant cells are bound to the surface of the liposome, resulting in increased interaction of the liposomes with target cells [24] . The molecule can be covalently bound to the liposome, either by using a spacer molecule or by binding directly to a hydrophobic anchor in the phospholipid bilayer. In many cases, a spacer arm is used to enhance binding to the tumor cells by reducing interference from other surface molecules on the liposome that may have been added to increase the circulation half-life or to increase hydrophilicity [25] . A wide range of molecules has been used for active targeting, including glycoproteins, glycolipids, peptides, growth factors, and monoclonal antibodies (MoAbs) [3, 6, 26] . Although MoAbs are expensive, are time consuming to produce, and may result in undesirable immune reactions in vivo , they have the advantage of excellent specifi city and signifi cantly increase the ability of liposomes to deliver PS selectively to malignant cells [27] . Some studies have used antibody fragments (at the cost of potentially decreasing specifi city) to minimize adverse immune reactions [28] . Other nonantibody ligands are often less expensive and carry a lower risk of inducing immune reactions: however, they do not have such high specifi cities for tumor cells, as many normal cells express the same receptors.
One application of liposomally encapsulated BPD was to destroy lymphatic vessels that might be responsible for allowing tumors to metastasize even after surgery [29] . Many tumors produce vascular endothelial growth factor C (VEGF-C) or VEGF-D, factors that promote the formation of new lymphatic vessels (lymphangiogenesis). The newly formed lymphatic vessels enable tumor cells to travel from the primary tumor to the regional lymph nodes from whence they can spread throughout the body. Tammela et al. [29] fi rst used the mouse ear containing tumors formed by mouse melanoma cells or human lung tumor cells after 2 weeks when the primary tumors had become established and lymphangiogenesis had been induced. Liposomal BPD accumulated specifi cally in the lymphatic vessels, and after illumination, they started to shrink and fragment and became leaky. When the experiment was repeated with tumors in the fl anks of mice and PDT was followed by surgery, the mice had a much lower relapse rate than those that underwent surgery alone. Finally, they demonstrated PDT shutdown of lymphatic vessels in a large animal model (leg and hoof of a pig).
There have been several studies examining the use of liposomally encapsulated PS to mediate antimicrobial photodynamic inactivation (PDI) [30 -33] . There is a well-known requirement for optimal antimicrobial PS to either possess one or more cationic charges on the PS itself or alternatively on the delivery vehicle in which the PS is contained [34] . Therefore, the liposomes for delivery of antimicrobial PDI are constructed to contain cationic lipids such as N -[1-(2,3-dioleoyloxy)propyl]-N , N , N -trimethylammonium chloride [33] or cationic detergents such as (1 S ,2 S )-N -hexadecyl-Nmethylprolinolinium bromide [32] . Longo et al. [35] used aluminum-chloride-phthalocyanine encapsulated in cationic liposomes to mediate PDI of oral bacteria and went on to test the antimicrobial PDT protocol in a clinical trial of 10 patients with carious lesions of the teeth.
Lipoplexes
Lipoplexes are complexes of cationic liposomes with other molecules (most commonly, negatively charged polynucleic acids), and have been most commonly used in gene therapy, for the delivery of nucleic acids such as DNAs and small interfering RNAs [36] . The cationic liposomes are created using positively charged cationic lipids (cytofectins). Recent studies have begun testing lipoplexes as a possible delivery system for negatively charged PS, and there is reason to believe that lipoplexes may improve the activity and specifi city of the PS. For example, chlorin e6 (ce6) (Porphyrin Products, Inc., Logan, UT, USA) (see Figure 2C ), a derivative of natural chlorophyll a, is a hydrophilic PS with seemingly limited potential, as it has low retention in tumor tissues and low potency [37] . However, when complexed with cationic liposomes, ce6 showed increased cellular uptake in vitro and selective targeting of tumor tissues in vivo , as well as increased retention within the tumor cells [38] . The use of cationic liposomes was crucial, as complexation effi ciency of ce6 was higher than 90 % with these liposomes, as compared with < 12 % for neutral and negatively charged liposomes. These fi ndings suggest that lipoplexes would be a profi table area of research for PS delivery systems.
Nanoemulsions
Nanoemulsions are yet another proposed method for the efficient delivery of PS and are promising as a therapeutic option as they are easy to prepare and thermodynamically stable [39] . They consist of dispersions of oil and water that have dispersed phase droplets of size 20 -200 nm and are often stabilized with a surfactant and co-surfactant [40] . Due to the nanosize range of the droplets, they are optically transparent and may be stored without the occurrence of sedimentation or droplet coalescence. Studies have demonstrated that nanoemulsions can enhance preferential delivery of PS to tumor sites and thus diminish the toxic side effects of PDT [41] . The application of nanoemulsions in PDT is likely to be in topical application of PS to the skin or to other mucosal surfaces. Primo et al. [42] formulated Foscan ( meta -tetrahydroxyphenyl chlorin, mTHPC) (Scotia Pharmaceuticals Ltd, Guilford, Surrey, UK) (see Figure 2D ) in a nanoemulsion composed of soy-phosphatidylcholine Epikuron 170/Tween 80 and nonionic surfactants Poloxamer 188/Span ® 80. This formulation showed improved transdermal transport after 6 h. The same group [43] also investigated a magnetic nanoemulsion composed of biodegradable surfactants and biocompatible citrate-coated cobalt ferrite-based magnetic fl uid to encapsulate ZnPC ( Figure 2B ) with the intention of combining PDT and magnetohyperthermia to produce synergistic cell killing.
5-Aminolevulinic acid (ALA) is not a PS itself but is a well-known precursor of the naturally formed PS, protoporphyrin IX [PPIX; (Porphyrin Products, Inc., Logan, UT, USA) see Figure 2E ] via enzymes of the heme biosynthetic cycle [44] (see Figure 4 ) . When exogenous ALA is applied to tumors or other unwanted tissue, the feedback inhibition of the heme cycle is bypassed and excess PPIX is accumulated after a period of a few hours. As ALA is often topically applied, methods of increasing uptake and penetration through the skin have been intensively investigated [45] . For instance, Maisch et al. [46] used a nanoemulsion consisting of 30-nm particles of egg lecithin to increase ALA delivery through a full-thickness ex vivo skin model. Biofrontera has developed this BF-200 ALA nanoemulsion formulation in clinical trials of actinic keratoses [47] .
Nanocells
Nanocells are a newly proposed technology that has been specifi cally designed to enhance drug delivery to solid tumors [48] . The traditional treatment method for tumors, which involves the simultaneous administration of chemotherapy and anti-angiogenesis agents, can actually inhibit the action of the chemotherapy agent. First, the action of the anti-angiogensis agent eventually decreases the blood supply to the tumor cells, making it more diffi cult for therapeutic concentrations of the chemotherapy drug to reach the tumor [49] . Second, the inhibited blood supply results in the accumulation of hypoxia-inducible factor 1 α in the tumor, which leads to increased tumor invasiveness and resistance Exogenous ALA is added that bypasses feedback control inhibition of ALA synthase. Because the rate-limiting step is the introduction of iron into PPIX by ferrochelatase to form heme, the levels of PPIX build up and allow effective PDT to be carried out.
to chemotherapy [50] . The nanocell is designed to avoid this scenario by sophisticated packaging of the two drugs: it consists of a nuclear nanoparticle (containing the chemotherapy agent) within an extra pegylated lipid envelope (containing the anti-angiogenesis agent). When the nanocell is absorbed by the tumor, the outer envelope releases the anti-angiogenesis agent, thus shutting down the blood supply to the cancer cells. The inner nanoparticle then releases the chemotherapy agent, which can easily access the tumor cells, as the nanocell is already trapped inside the tumor. In addition to ensuring effi cient delivery, this strategy results in decreased toxicity as the drugs are isolated from healthy cells. So far, this technique has only been demonstrated with chemotherapy agents, but it may be possible to design nanocells that can carry photosynthesizers. Early studies have shown preferential uptake of nanocells by tumors, which could be enhanced by active targeting in a similar manner to that of liposomes [40] .
Porphysomes
Porphysomes are an interesting hybrid of a lipid nanoparticle and a potential PS developed by Gang Zheng ' s laboratory in Toronto [51, 52] . They consist of nanovesicles formed from self-assembled porphyrin bilayers that generate large, tunable extinction coeffi cients, structure-dependent fl uorescence self-quenching and unique photothermal and photoacoustic properties. The basic building block is a conjugate between pyropheophorbide and a cationic phospholipid ( Figure 5 A) that spontaneously assembles into 100-nm particles composed of two high-density layers, ca. 5 nm thick in total and separated by a ∼ 2-nm gap. Each layer is thought to correspond to a monolayer of porphyrin lipid (see Figure 5B ). Because As described by Lovell [51] , lysophosphatidylcholine pyropheophorbide a (A) spontaneously assembles into nanovesicles designated " porphysomes " (B).
the porphyrins are packed in high density, they undergo selfquenching and at short time points can mediate photoacoustic and photothermal effects. However, at later time points, they dissociate in vivo and the released porphyrins can then mediate PDT.
Polymer-based nanoparticles
Polymeric nanoparticles have recently emerged as a new and promising tool for the delivery of drugs in PDT. Polymerbased PDT drugs offer several key advantages over molecular PDT drugs such as the ability to deliver a large amount of PS to the target area, fl exibility toward surface modifi cation for better effi ciency, the ability to prevent degradation in the living biological environment, and the possibility of being loaded with multiple components such as targeting ligands and contrast agents. These advantages have a potential to improve several aspects of PDT such as tumor selectivity and hydrophobicity of the PS. The size of polymeric nanoparticles makes them an excellent tool for drug delivery. Tumor tissue has abnormally leaky blood vessels (with fenestrae up to 780 nm [53] ) and nanoparticles preferentially escape from normal vasculature into the tumor, where they are subsequently retained due to poor lymphatic drainage. This effect is known as EPR [54] . A variety of polymer nanoparticles have been used to create PDT agents, and the structures are illustrated in Figure 6 . These include synthetic polymers like polylactidepolyglycolide copolymers (PLGA), N -(2-hydroxypropyl)-methacrylamide (HPMA) copolymers, and polyacrylamide (PAA). Natural polymers composed of polysaccharides such as chitosan and alginate and proteins such as albumin and collagen have also been used. Following is a summary of recent polymeric nanoparticle applications in PDT.
Poly( D , L -lactide-co-glycolide)
PGLA (see Figure 6A ) is a polymer made from a mixture of lactic acid and glycolic acid monomers that has been widely investigated for drug delivery due to its ease of formulation and biodegradability [61] . PS such porphyrins, chlorins, hypericin, and phthalocyanines (see Figure 2 ) have been loaded into PLGA nanoparticles and investigated for their potential in PDT. It has been reported that hypercin-loaded PLGA nanoparticles demonstrated a higher photoactivity than the free drug in NuTu-19 ovarian cancer cells [62] . The same effect was demonstrated in another study, where the [56] , (C) HPMA [57] , (D) 18m-ALA-dendrimer [58] , (E) PEG-PLL [59] , and (F) chitosan [60] .
effi cacy of PDT with meso -tetra(4-hydroxyphenyl)porphyrin ( m -THPP) (see Figure 2D with one extra double bond)-loaded nanoparticles was compared with that seen with the free drug in EMT-6 mammary tumor cells [63] . Treatment with the 50:50 PLGA nanoparticles allowed for lower drug doses and shorter time intervals between drug administration and irradiation when compared with free m -THPP. ZnPc has also been loaded into PLGA nanoparticles and successfully used in PDT [55] .
Several studies have been done to determine the dependence of PDT effi ciency on properties of PLGA such as size and copolymer molar ratios. It has been reported in several studies that effi cacy of PDT increases as the size of the nanoparticle decreases [64, 65] . When verteporfi n was loaded into two PLGA nanoparticles, one 167 nm and the other 370 nm in diameter and tested on EMT-6 mammary tumor cells. It was found that the smaller nanoparticles exhibited a higher phototoxic effect than the larger ones or the free drug [64] . Another study examined three different PLGA nanoparticles with mean diameters of 117, 285, and 593 nm were loaded with m -THPP. The 117-nm particles demonstrated the fastest m -THPP release and highest rate of ROS production in vitro [65] . The improved performance of the smaller PLGA nanoparticles may be due to better intracellular uptake of the drug as well as a larger fraction of the particle that is exposed to its surroundings, which allows for a higher drug release rate [66] . It has also been found that the molar ratio of polylactide (PLA) to polyglycolide (PGA) affects the biodegradation rate [67] and the phototoxicity of the loaded PS. When m -THPP was loaded into same size nanoparticles with three different molar ratios, its in vitro phototoxicity increased in the order of 50:50 PLGA > 75:25PLGA > PLA [63] . PGA is more hydrophilic than PLA; thus, this demonstrates that the phototoxicity of the incorporated PS depends on the lipophilicity of the polymer nanoparticle [68] .
Polyacrylamide
PAA (see Figure 6B ) is a favorable substance for systemic administration because it is highly water-soluble, which prevents aggregation. It has been demonstrated to be nontoxic and biologically inert [69] . Another advantage of PAA nanoparticles is that biodegradable cross-linkers can be introduced to make them slowly biodegradable, which improves their bioelimination in vivo [70] . PAA with nonbiodegradable cross-linkers has also been used successfully in PDT [71] . The polymer was shown to be an effective PDT agent when loaded with PS such as methylene blue (MB) [71, 72] and Photofrin [73] . In one study, 2-to 3-nm meta -tetra(hydroxyphenyl)-chlorin ( m -THPC)-loaded PAA particles were prepared and successfully used in PDT to kill rat C6 glioma cells, proving to be as effective as the free drug [74] . The main advantage of these particles is their small size, which means 1 O 2 should diffuse more rapidly out of them and they can be removed from the body by renal clearance. PAA-coated MB particles were also successfully used in PDT to eliminate bacterial infections [75] . The nanoparticles inhibited biofi lm growth of both Gram-positive and Gram-negative strains, but killing effi ciency was much higher for the Gram-positive bacteria.
N -(2-Hydroxypropyl)methacrylamide
HPMA (see Figure 6C ) is a biocompatible copolymer that has been shown to passively accumulate in tumors and can be easily formulated to include targeting ligands [57] . HPMA copolymer-bound drugs have been developed for the combination of PDT and chemotherapy [76] . It has been demonstrated using two different cancer models (Neuro 2A neuroblastoma [76] and human ovarian carcinoma [77] ) that this novel approach is more effective than PDT or chemotherapy alone.
Dendrimers and hyperbranched polymers
Dendrimers are highly branched polymeric materials that have been used to deliver 5-ALA. ALA delivery is diffi cult due to its hydrophilic nature. Battah et al. [58] prepared an ALA-dendrimer, [1,3,5- 
benzene 18 trifl uoroacetic acid salt (18m-ALA; see Figure 6D ). An in vitro study demonstrated that dendrimers such as 18m-ALA could be used to carry ALA into PAM 212 murine keratinocyte and A431 human epidermoid carcinoma cell lines. It also showed that the dendrimer ALA nanoparticles are more effi cient at porphyrin production than free ALA.
Li and Aida [78] have reviewed the fi eld of dendrimeric porphyrins, phthalocyanines, and other tetrapyrroles. Kataoka ' s laboratory has prepared dendrimer PS based on both a Zn-porphyrin and on a Zn-phthalocyanine [79] . The porphyrin dendrimers were complexed with poly-l -lysine-PEG (PEG-PLL; see Figure 6E ) block copolymers to form nanocarriers [80] . Interestingly, the larger the dendrimer (i.e., the higher the generation number), the smaller was the overall size of the nanocarrier. Dendrimeric phthalocyanines (DPc) with carboxyl groups at the periphery were complexed with PEG-PLL in a similar manner to form nanocarriers (DPc/m) with 50 nm diameter [81] . The nanoparticles were taken up into A549 human lung cancer cells, accumulated in lysosomes, and were released upon illumination. Nude mice with A549 tumors received DPc or DPc/m intravenously at a dose of 1.85 mg/kg, and after 24 h, tumor sites were irradiated with a 670-nm diode laser with a light dose of 100 J/cm 2 . Mice treated with DPc/m-PDT showed a much better tumor response than those with DPc-PDT.
Li et al. [82] prepared conjugates between the PS ce6 and hyperbranched poly(ether-ester), HPEE. HPEE-ce6 nanoparticles were synthesized by carbodiimide-mediated reaction between HPEE and ce6 and characterized by ultraviolet-visible absorption spectroscopy (UV-Vis) and transmission electron microscopy. The uptake and phototoxicity of HPEE-ce6 nanoparticles toward human oral tongue cancer CAL-27 cells was detected by confocal laser scanning and MTT assay. The HPEE-ce6 nanoparticles showed signifi cantly greater PDT effect than free ce6.
Natural polymers
Natural polymers such as proteins and polysaccharides have also been studied for potential use in PDT. Human serum albumin has been loaded with the PS pheophorbide. The nanoparticles were incubated with Jurkat cells for 24 h, and the treatment resulted in higher phototoxicity and lower dark toxicity than free pheophorbide [83] . In a study with polysaccharide nanoparticles, 5,10,15-triphenyl-20-(3-Nmethylpyridinium-yl)porphyrin was encapsulated in marine atelocollagen/xanthan gum [84] . The incorporated PS displayed almost four times greater phototoxicity toward HeLa cells when prepared with the nanoparticles than with phosphatidylcholinelipidic emulsion.
Chitosan
Chitosan is a β -1,4-linked polymer of glucosamine (2-amino-2-deoxy-β -d -glucose) and lesser amounts of N -acetylglucosamine. It is a derivative of chitin (poly-Nacetylglucosamine) ( Figure 6F ) and is the second most abundant biopolymer after cellulose. Chitosan was fi rst discovered in 1811 by Henri Braconnot [85] , a French chemist and pharmacist. Bracannot observed that a certain substance (chitin) found in mushrooms did not dissolve in sulfuric acid. Later in the century, chitin was found in crustaceans (such as crabs, lobsters, shellfi sh, and shrimp), the indigestible outer skeleton of insects, and the material from which the cell walls of the mycelial fungi are made. Over the last 200 years, the study and application of chitosan has taken on many different forms, but in recent years, it has been used to manufacture nanoparticles that have been investigated for improved drug delivery [86] .
Reza-Saboktakin et al. [87] prepared biodegradable polymeric nanoparticles loaded with PS m -THPP. N -Sulfonato-N , O -carboxymethylchitosan was grafted with polymethacrylic acid. The nanoparticles were loaded with m -THPP (10% -30 % loading) and tested for PDT killing of 14C carcinoma cells. After 6 h of incubation, the phototoxicity of the nanoparticles was comparable with that of free m -THPP.
Lee et al. [88] prepared hydrophobically modifi ed glycol chitosan (HGC) nanoparticles by self-assembling amphiphilic glycol chitosan-5 β -cholanic acid conjugates. Ce6 was chemically conjugated to the glycol chitosan polymers, resulting in amphiphilic glycol chitosan-ce6 conjugates that formed self-assembled nanoparticles in aqueous condition. Both ce6-loaded glycol chitosan nanoparticles (HGC-ce6) and ce6-conjugated chitosan nanoparticles (GC-ce6) had similar average diameters of 300 -350 nm, a similar in vitro 1 O 2 generation effi cacy under buffer conditions, and a rapid cellular uptake profi le in the cell culture system. However, compared with GC-ce6, HGC-ce6 showed a burst of drug release in vitro (65 % released from the particles within 6.5 h). When injected through the tail vein into nude mice bearing HT29 human colon carcinoma tumors, HGC-ce6 did not accumulate effi ciently in tumor tissue, refl ecting the burst in the release of the physically loaded drug, whereas GC-ce6 showed a prolonged circulation profi le and a more effi cient tumor accumulation. PDT (2.5 mg/kg) ce6 followed by two separate illuminations at 4 and 12 h postinjection with a red laser (671 nm, 220 mW/cm 2 ) for 30 min gave best tumor growth delay with GC-ce6, whereas HGC-ce6 was less effective, and free ce6 gave hardly any response.
The same group [89] prepared similar nanoparticles from glycol-chitosan with PPIX conjugated and found these amphiphilic PPIX-eGC conjugates formed a stable nanoparticle structure in aqueous condition, wherein conjugated PPIX molecules formed hydrophobic inner cores and they were covered by the hydrophilic GC polymer shell. PPIXeGCeNP showed a self-quenching effect, but after cellular uptake, the compact structure gradually decreased to generate a strong fl uorescence signal and 1 O 2 generation when irradiated. Nude mice with SCCVII squamous cell carcinomas were intravenously injected via a tail vein with free PPIX or PPIX-GC-NP (20 mg/kg of PPIX). After 1 day postinjection, tumors were irradiated with a 633-nm HeNe laser, 3 mW/cm 2 for 30 min. PPIX-GC-NP gave a pronounced tumor destruction and growth delay not seen with free PPIX.
Pegylated polymers
One problem with using polymer nanoparticles for drug delivery is that they tend to be taken up by macrophages after intravenous administration [90] . To reduce this uptake, the nanoparticle can be coated with PEG, which allows for longer plasma circulation and better accumulation in tumors. In one study, it was reported that pegylation (the attachment of PEG) of PLL and ce6 conjugates increased the selectivity and improved the phototoxicity of PDT in OVCAR-5 ovarian cancer cell lines [59] . In an in vivo study, hexadecafl uoro ZnPc was loaded into PEG coated PLA nanoparticles and tested for photodynamic activity and tumor response in EMT-6 tumorbearing mice [91] . The results showed an improved response and longer tumor sensitivity to PDT compared with treatment with the same PS prepared in Cremophor El (CRM) emulsions. Another way to improve tumor selectivity of the polymer nanoparticle is by conjugating its surface with tumor-specifi c ligands for active targeting. As an example, in an in vitro study done with MDA-MB-435 human breast carcinoma F3-targeted PAA nanoparticles were loaded with Photofrin and iron oxide and were successfully concentrated within the nuclei of the cells [73] . Subsequent administration of light caused cell death. Active targeting is a major advantage of polymeric nanoparticles because they can be packed with multiple targeting ligands and they frequently exhibit better selectivity than targeted molecular drugs [92] .
Micelles
Micelles are so-called colloidal dispersions (with particle size normally within the 5-to 100-nm range) of aggregates of surfactant molecules dispersed in a liquid colloid. Such colloids are spontaneously formed under certain concentration and temperature by amphiphilic or surface-active agents. These surfactant molecules consist of two clearly distinct regions with opposite affi nities toward a given solvent (see Figure 7 ) . Micelles have been widely used to carry hydrophobic drugs, which are physically entrapped in and/or covalently bound to the hydrophobic core. Micellar nanocarriers demonstrate a series of attractive properties as drug-delivery systems, such as improved bioavailability, enhanced permeability across the physiological barriers (EPR effect), and substantial benefi cial changes in drug biodistribution [93, 94] . Micelles can be classifi ed in two general groups based on the nature of the amphiphilic core: polymeric micelles, which are formed by block copolymers consisting of hydrophilic and hydrophobic monomer units, and micelles prepared from water-soluble polymers conjugated with lipids.
Polymeric micelles
Polymeric micelles represent widely used nanocarriers, comprising several possible classifi cations and types of polymers and copolymers. Among others, PEG-b-poly(caprolactone) (PEG-PCL) diblock copolymers seem to be successful with the delivery of photosensitizing agents. Li et al. [95] studied the formulation of hydrophobic PPIX PEG-PCL micelles and compared their PDT response with that of free PPIX. PEG-PCL micelles have also been used for the encapsulation of phthalocyanines [96] , chlorins [97, 98] , and pheophorbides [99] with successful results. These fi ndings suggest that PEG-PCL micelles have great potential as a drug-delivery system for hydrophobic photodynamic sensitizers.
The encapsulation of dendrimer PS can be also improved by means of PEG-PLL micelles [81, 100, 101] .
Using another biocompatible and biodegradable block copolymer, PEG-b-poly( d,l -lactide) (PEG-PLA), Gao et al. [102] recently published the nanoscopic structure-property relationships of micelle-delivered PPIX and established a viable formulation for in vivo evaluation of antitumor effi cacy. This group also explored the advantages of using PEG-PLA micelles for the encapsulation of mTHPC in head and neck cancer treatment [103, 104] . Pluronics (poloxamers) are commercially available watersoluble triblock copolymers of poly(ethylene oxide) and poly(propylene oxide) (PEO-PPO-PEO) and have been frequently used as a solubilization agent in drug formulations. Gallavardin et al. [105] used the pluronic nanoparticles for encapsulating two-photon chromophores. Chowdhary et al. [106] compared the pluronic P123 formulation with a lipidbased system to improve the verteporfi n delivery to lipoproteins in tumor and arthritis mouse models.
Some authors reported the use of pH sensitivity of the micelle to release the PS selectively at the target site. It is known that tumors and infl amed tissues exhibit a decreased extracellular pH as well as some intracellular compartments such as lysosomes or endosomes. Low pH may change the polymer polarity and structure causing the PS deliver [107] . Following this strategy, Le Garrec et al. [108] synthesized different N -isopropylacrylamide (NIPAM) copolymers to prepare pH-responsive micelles encapsulating AlPc. NIPAM copolymers exhibit substantially lower cell cytotoxicity and greater activity in vivo than that seen with Cremophor micelle formulation. Koo et al. [109] also demonstrated an enhanced therapeutic response of PPIX-encapsulated pH-responsive micelles for cancer treatment.
PEG-lipid micelles
The structure of PEG-lipid micelles correspond to that of amphiphilic copolymers. However, the hydrophobic part is represented by a lipid instead of hydrophobic polymer block. There are several water-soluble polymers-lipid conjugates commercially available or they can be easily synthesized; however, phosphatidyl ethanolamine (PE) constituted the most used diacyl phospholipid chain. The lipid part receives the hydrophobic PS, while PEG prevents rapid uptake of the particles by RES [110] . Torchilin et al. [111 -113] has extensively studied PEG-PE micelles as PS delivery systems. The use of PEG-PE micelles allowed for a 150-fold increase in the solubilization of tetraphenylporphyrin (TPP), compared with the nonformulated drug. TPP-loaded PEG-PE micelles were additionally modifi ed with tumor-specifi c monoclonal 2C5 antibody (mAb 2C5), which resulted in signifi cantly improved anticancer effect of the drug under the PDT conditions against murine Lewis lung carcinoma in vivo in female C57BL/6 mice. Zhang et al. [114] developed micellar PEG-DSPE formulations for increasing the solubility of lipophilic benzoporphyrins.
Cremophor EL is another easily commercially available micelle constituent. It is polyethoxylated castor oil and has been widely used for the formulation of a variety of hydrophobic drugs, also in PDT, as a simple and biocompatible solubilization system [115 -119] .
Silica-based nanoparticles
Silica is a major component of sand and glass, and it has been used in the synthesis of nanoparticles. Functional groups can also be added to the surface of silica nanoparticles (SiNPs), making them appealing for designs for different applications. Very recently, SiNPs have emerged as promising vectors for PDT applications [120] . Among the variety of nanoparticles, SiNPs have several advantages: their particle size, shape, porosity, and monodispersibility can be easily controlled during their preparation; furthermore, a variety of precursors and methods are available for their syntheses, allowing fl exibility and thus numerous PDT drugs to be encapsulated. SiNPs also have advantages as drug vectors. There is no swelling or porosity change occurring with change of pH. Moreover, SiNPs are known for their compatibility in biological systems and are not subject to microbial attack. Although these SiNPs do not release the entrapped PS, their porous matrix is permeable to molecular as well as 1 O 2 . Therefore, the desired photodestructive effect of the drug will be maintained even in the encapsulated form.
There are many methods to make SiNPs, such as organically modifi ed silicates (ORMOSIL), hollow silica, mesoporous SiNPs (MSN), and sol-gel method. The St ö ber procedure, which is known to generate amorphous SiNPs of a controlled size [121] , the reverse microemulsion (water-in-oil) method, and recently direct microemulsion (oil-in-water) procedure [122, 123] , and the sol-gel method have all been applied to design nanoparticles for PDT applications. Both noncovalent encapsulation and covalent conjugation have been used as methods for the immobilization of the PS inside or on the surface of the SiNPs [122] . Noncovalent encapsulation is the most frequently described method, whereas covalent linkage of the PS appears to be more effi cient, as no release of the PS from the nanoparticles occurs.
MB (see Figure 2I ) is a heterocyclic aromatic chemical compound with photodynamic toxicity. Intravenous administration of MB is Food and Drug Administration approved for methemoglobinemia. However, clinical use of MB is limited because of the poor penetration of this drug in the cellular compartment of the tumor. Encapsulation of MB inside SiNPs is a way to vectorize it and protect it from degradation. Tang et al. [72] was the fi rst to encapsulate MB in ORMOSIL. They compared three types sub-200-nm nanoparticles composed of PAA, sol-gel silica, and ORMOSIL, respectively. As a result, they showed that although PAA nanoparticles exhibited the most effi cient delivery of 1 O 2 and positive photodynamic effect on rat C6 glioma tumor cells, the sol-gel SiNPs had the best MB loading but the least effi cient 1 O 2 delivery. In 2005, Roy et al. [124] established the feasibility of using ORMOSIL nanoparticles as a carrier for PS. This formulation of nanoparticles overcomes many of the limitations of " unmodifi ed " SiNPs. The presence of both hydrophobic and hydrophilic groups on the precursor alkoxy organosilane helps them to self-assemble as both normal micelles and reverse micelles under appropriate conditions. ORMOSIL nanoparticles are prepared from oil-in-water microemulsions, avoiding corrosive solvents such as cyclohexane and through a complex purifi cation process. Their organic groups can be further modifi ed for the attachment of targeting molecules and can be possibly biodegraded through the biochemical decomposition of the silicon-carbon bond. 2-Devinyl-2-(1-hexyloxyethyl) pyropheophorbide (HPPH) (see Figure 2H) , an effective ORMOSIL nanoparticle bound to porphyrin. As described by Hocine et al. [126] , a trimethoxysilane functionalized tris-cationic porphyrin was prepared and copolymerized intro a SiNP.
PS that is in phase I/II clinical trials, was encapsulated into ORMOSIL with diameter of 30 nm [125] by copolymerization mediated by controlled hydrolysis of triethoxyvinylsilane and the triethoxysilane-derivatized HPPH in micellar media (see Figure 8 ) . In vitro studies demonstrated the active uptake of drug-doped nanoparticles into the cytosol of tumor cells. Signifi cant damage to such photosensitized tumor cells was observed upon irradiation with light of wavelength 650 nm. Following the pioneering work of Roy et al. [124] and Yan et al. [127] , many other researchers encapsulated PS inside SiNPs by noncovalent methods. Different PS, such as MB [72] and PPIX [128] have been encapsulated or covalently linked to ORMOSIL particles. Higher 1 O 2 -generation quantum yield was found for the encapsulated PS than for free PS with m -THPC [127] , HPPH [124] , or HA [129] .
There is a strong relationship between the sites of subcellular localization of the PS and photodamage to nearby organelles involved in cell death. Zhou et al. [129] constructed porous hollow silica nanospheres and embedded HA. Compared with free HA, the silica embedded HA showed superior light stability, higher 1 O 2 generation, and in vitro experiments showed the mitochondrial membrane potential was destroyed as evidenced by rhodamine-123 staining [129] .
The silicon phthalocyanine, Pc4 was encapsulated in ORMOSIL (Pc4SNP) with a size ranging from 25 to 30 nm based on hydrophobic silicon by the method modifi ed from Roy et al. [124] . Pc4SNP not only improved the aqueous solubility, stability, and delivery of the photodynamic drug but also increased its photodynamic effi cacy compared with free Pc4 molecules. Pc4SNP generated photoinduced 1 O 2 more effi ciently. They found Pc4SNP was more phototoxic to A375 or B16-F10 melanoma cells than free Pc4. The mechanism studies of Pc4SNP photodamaged melanoma cells showed an increase of intracellular protein-derived peroxides, suggesting a type 2 ( 1 O 2 ) mechanism for phototoxicity. More Pc4SNP than free Pc4 were localized in the mitochondria and lysosomes and cause cell death primarily by apoptosis.
Covalent coupling of the PS inside the nanoparticles offered an advantage in that this covalently linked nanofabrication meant that the PS is not released during systemic circulation. Prasad and collaborators fi rst reported the covalent incorporation of PS molecules into ORMOSIL nanoparticles by synthesizing iodobenzyl-pyro-silane (IPS) with vinyltriethoxysilane in the nonpolar core of Tween-80/water microsmulsion. IPS is a precursor for ORMOSIL with the linked PS iodobenzylpyropheophorbide [125] . The covalently incorporated PS molecules are of an ultralow size (approx. 20 nm), which retained their spectroscopic and functional properties and could robustly generate cytotoxic 1 O 2 molecules upon photoirradiation. The synthesized nanoparticles are highly monodispersed and stable in aqueous suspension. Moreover, these nanoparticles are also avidly taken up by tumor cells in vitro and exhibit a phototoxic effect on the cultured cells proportional to the cellular uptake, thereby highlighting their potential in diagnosis and PDT of cancer.
PPIX can be considered as a natural PS because ALA is a metabolic precursor in the biosynthesis of heme, and PPIX is the immediate precursor to heme (see Figure 4) . Qian et al. [130] encapsulated PPIX in ormosil nanoparticles (25 nm diameter) following Prasad ' s method. They showed PDT effect performed on HeLa cells, and the cell structures were destroyed by a 532-nm light source at low dose (2 mW/cm 2 , 2 min). Simon et al. [131] recently published the synthesis and properties of PPIX in ORMOSIL nanoparticles prepared by Prasad ' s method. There is a strong relationship between the sites of subcellular localization of the PPIX and photodamage to nearby organelles involved in cell death. The intracellular accumulation of PPIX SiNPs takes place in the cytoplasm of cells. Higher ROS generation, which leads to cell destruction, was found correlated to the presence of PPIX SiNPs in both HCT 116 and HT-29 colon cancer cells [131] .
MSN have been also used for various biomedical applications such as cell markers or drug and gene delivery platform. MSN are a suitable carrier for hydrophobic PS and protect the PS from degradation due to their large surface area and pore volume, as well as uniform pore size. Tu et al. [132] conjugated PPIX with MSN through covalent bonding to yield PPIX modifi ed MSN for PDT. In in vitro experiments, they found that the uptake of the PPIX-modifi ed particles by HeLa cells was quite effi cient. An almost linear relationship between cellular uptake and dosage was observed. Both necrosis and apoptosis could be observed depending on the concentration and dosage-and irradiation timedependent loss of cell viability was observed. The same group grafted a phosphorescent Pd-meso -tetra(4-carboxyphenyl)porphyrin (PdTPP) as the PS in prepared MSN [133] .
A marked advantage of using nanoparticles is that they can be used as multifunctional platforms. A single particle platform that combines two functions has been described by Rossi and collaborators in 2007 [134] . MB as a PS was added to the silica precursor tetraorthosilicate during the growth of the silica layer and was therefore entrapped in the silica matrix. Then the magnetic cores were prepared by coprecipitation of Fe
Gold nanoparticles
Gold nanoparticles (AuNPs) have been used in two ways in PDT: fi rst, as drug-delivery platforms in a similar manner to other inorganic nanoparticles (see Figure 9 A) ; second, as surface plasmon-enhanced agents taking account of the nonlinear optical fi elds associated with very close distances to metal nanoparticles (see Figure 9B ).
Standard AuNPs
The conjugation of PS molecules to AuNPs [123] and other inorganic nanoparticles [124, 137 -139] represents an effective way to improve the targeting effect and effi cacy for cancer treatments [66, 123, 140 -145] .
It is possible to modify the AuNPs either covalently or noncovalently with PS [146] . Moreover, the small size of AuNPs can be presented as a benefi t, allowing them to permeate tissue and the leaky vasculature of tumors [147] . In that way, tunable AuNPs can serve as both diagnostic and therapeutic tools for cancer [148] once they are recognized for their chemical inertness and have minimum toxicity as well [149] .
The AuNPs have good biocompatibility, versatile surfaces, tunable sizes, and unique optical properties [150] . When coated with PEG, which has been approved for human intravenous application, they can result in promising drug-delivery systems for cancer PDT [123] due to the stabilization by steric repulsion and inhibition of colloid aggregation in physiological conditions [151, 152] .
Although PEG provides solubility in water and minimizes any protein adsorption [144] , the AuNP surface provides an amphiphilic environment for lipophilic PDT drugs [123] . The PEG-AuNP drug-delivery systems for PDT in HeLa cells were previously evaluated and showed effi cient drug release by membrane-mediated diffusion when the noncovalent adsorption of the PS to AuNPs was used [153] .
Using the noncovalent delivery of Pc4 with PEG-gold NPs, Cheng et al. [123] observed surprisingly effi cient release and penetration of the drug into the tumor in vivo . In addition, both the drug and the AuNPs were excreted by renal clearance and the hepatobiliary system. Another study also revealed that pegylated AuNP-Pc4 conjugates dramatically improved the delivery of the drug. In addition, the Pc4 could be well dispersed in aqueous solutions once it was formulated as an AuNP conjugate [123] .
AuNP-modifi ed porphyrin-brucine conjugates have been claimed to represent a signifi cant improvement in PDT compared with free PS [146] . Both para and meta substitution patterns, when bound to modifi ed AuNPs, were able to effectively reduce tumor size in vivo , with complete tumor regression. In vitro , PDT of synthesized hematoporphyrin-nanogold composites was much enhanced if compared with that of the original PS alone [145] . It was also concluded that nanocomposites with gold particles of 45 nm presented better results than the ones with 15-nm particles, which could be connected to the fact that bigger particles can transport more porphyrin molecules into malignant cells.
Plasmon-enhanced AuNPs
The phenomenon of localized surface plasmon resonance is based on the interaction of the conduction electrons of metal nanostructures with incoming light [154] . The electromagnetic waves induce an oscillation of these electrons and resonances can be observed. These resonances depend on parameters such as the kind of metal and its composition (in the case of a mixture), geometry (size, shape), and immediate environment. The last is the basis for its potential use as a sensor: for example, using an affi nity layer, certain molecules bind to the surface of such a structure, infl uencing, and shifting the resonance, which can be observed and used as the sensed signal for readout. Molecular plasmonics represent the fi eld that deals with localized surface (also called particle) plasmon resonance effects in interactions with molecular components (usually bound to the surface of metal nanostructures). The observed effects can be used for novel conjugates for nano-optics (here the molecules act as a tool) as well as for biomolecular analytics aimed at molecular analytes.
A report from Fales et al. [155] in Vo-Dinh ' s laboratory showed that gold nanostars could be tuned for maximal absorption in the NIR spectral region and tagged with an NIR dye for surface-enhanced resonance Raman scattering. Silica coating was used to encapsulate the PS MB in a shell around the nanoparticles. Upon 785-nm excitation, surfaceenhanced Raman spectroscopy (SERS) from the Raman dye was observed, whereas excitation at 633 nm showed fl uorescence from MB. MB-encapsulated nanoparticles showed a signifi cant increase in singlet-oxygen generation as compared with nanoparticles synthesized without MB. This increased singlet-oxygen generation showed a cytotoxic effect on BT549 breast cancer cells upon laser irradiation.
Khlebtsov et al. [156] prepared novel composite nanoparticles consisting of a gold-silver nanocage core and a mesoporous silica shell functionalized with the photodynamic sensitizer Yb-2,4-dimethoxyhematoporphyrin (Yb-HP). In addition to the long-wavelength plasmon resonance near 750 -800 nm, the composite particles exhibited a 400-nm absorbance peak and two fl uorescence peaks, near 580 and 630 nm, corresponding to bound Yb-HP. The fabricated nanocomposites generated 1 O 2 under 630-nm excitation and produced heat under laser irradiation at the plasmon resonance wavelength (750 -800 nm). In particular, they observed enhanced killing of HeLa cells incubated with nanocomposites and irradiated by 630-nm light. Furthermore, an additional advantage of fabricated conjugates was an IR-luminescence band (900 -1060 nm), originating from Yb(3 + ) ions of bound Yb-HP and located in the long-wavelength part of the tissue transparency window. This modality was used to control the accumulation and biodistribution of composite particles in mice bearing Ehrlich carcinoma tumors in a comparative study with intravenously injected free Yb-HP molecules.
Semiconductor and quantum dot nanoparticles
Semiconductors are materials with conduction properties intermediate between metals and insulators. The typical structure is a crystalline lattice where the electron conduction band is <4 eV above the valence band. Electrons excited to the conduction band (either by an applied voltage or by absorption of light) leave behind electron holes, i.e., unoccupied states in the valence band. Both the conduction band electrons and the valence band holes contribute to electrical conductivity. Although hsemiconductors used in electronics are usually made from silicon doped with small amounts of other elements, other semiconductors will absorb or emit light and are composed of alloys of pairs of elements in the II -VI periodic groups (e.g., ZnO, ZnS, CdSe) or the III -V groups (GaAs, InN, InP, AlAs). These substances produce excitons on photon absorption (a bound state of an electron and hole that are attracted to each other by electrostatic force) (see Figure 10 A).
Zinc oxide and titanium dioxide
Both ZnO and TiO 2 can produce ROS upon light absorption by electron transfer reactions involving oxygen and water. The active species is thought to be mainly hydroxyl radical (HO · ) [157] , but superoxide anion and 1 O 2 are also produced [158, 159] . Most studies have examined excitation of these materials with UV light, but recently, attempts have been made to use visible light (often blue light) as well [160] .
Zhang et al. [161] used ZnO nanorods loaded with the cytotoxic drug daunorubicin to mediate synergistic killing of Typical QD with CdSe core, followed by a zinc sulfi de capping passivation layer covered by a biologically compatible layer made of thiol containing compounds. PS are covalently attached to the QD that can take part in FRET with the emission of the QD being used to excite the PS.
human hepatocarcinoma cells. UV illumination signifi cantly improved cytotoxicity over that seen with daunorubicin alone. TiO 2 has been more widely studied as a PS than ZnO in a process termed " photocatalysis, " which has been proposed as an antimicrobial strategy for disinfecting wastewater [162] . However, there have also been reports of the use of photoactivated TiO 2 as an anticancer treatment. Yamaguchi et al. [163] constructed TiO 2 nanoparticles by the adsorption of chemical modifi ed PEG on the TiO 2 surface. When C6 rat glioma cells (both as monolayers and as multicellular spheroids) were incubated with TiO 2 -PEG nanoparticles followed by UV illumination, 90 % of the cells were killed. Zhang and Sun [164] reported similar results by inactivating Ls-174-t human colon carcinoma cells using incubation with TiO 2 nanoparticles and ultraviolet A irradiation (UVA, 320 -400 nm) but had to use much higher concentrations (200 -1000 μ g/ml) possibly because they did not use PEG solubilization. Wang et al. [165] showed that TiO 2 -PDT could produce a therapeutic effect in vivo as well. They grew U87 gliomas in nude mice, injected TiO 2 nanoparticles around the subcutaneous tumor, and after 12 h exposed the tumor and irradiated it with UVA. Signifi cant areas of tumor necrosis and extended mouse survival were obtained by PDT.
Quantum dots
QD are semiconductor crystals whose size regulates the bandgap (difference in energy between the highest valence band and the lowest conduction band). The absorption spectrum has a relatively broad peak, but the fl uorescence emission is relatively narrow and tunable by size. The typical composition of the alloys in QD is chosen from cadmium selenide (CdSe), cadmium sulfi de, indium arsenide, and indium phosphide (see Figure 10B ). There have been scattered reports about the photoactivated generation of ROS after illumination with UV or visible light, but it is still uncertain whether they could be designed to carry out useful PDT [166] . Some workers have used QD as part of a Forster resonance energy transfer (FRET) pair to improve excitation of a standard PS. For instance, Samia et al. [167] used CdSe QD with an average diameter of 5 nm and linked to a silicon Pc PS(Pc4) through an alkyl amino group on the PS. Pc4 is a known PDT agent currently undergoing clinical trials [168] . For excitation wavelengths between 550 and 630 nm, Pc4 was directly activated. However, if wavelengths between 400 and 500 nm were used, the QD acted as a primary energy donor transferring excitation to Pc4 with a 77 % FRET effi ciency. In the process of investigating the two-step energy transfer mechanism in the QD/Pc4/oxygen system, they found that semiconductor QD alone could actually generate 1 Moreover, the amount of defect sites on the QD surface could be controlled to some extent using additional surface passivation layers [170] , which may systematically improve 1 O 2 generation.
Generalov et al. [171] suggested that upon entry into a cell, QD are trapped and their fl uorescence is quenched in endocytic vesicles such as endosomes and lysosomes. They investigated the photophysical properties of QD in liposomes as an in vitro vesicle model. Generation of free radicals by liposomal QD is inhibited compared with that of free QD. Nevertheless, QD fl uorescence lifetime and intensity increases due to photolysis of liposomes during irradiation. In addition, protein adsorption on the QD surface and the acidic environment of vesicles also lead to quenching of QD fl uorescence, which reappears during irradiation. Morosini et al. [172] used hydrophilic CdTe(S) QD conjugated to folate with different spacers (PEG or Jeffamine D-400) and examined phototoxicity against folate-receptor-positive or -negative cancer cells. They obtained evidence for foliate-receptor-mediated targeting and PDT effects using 515-or 658-nm light.
Fullerenes
Fullerenes are the third allotropic form of carbon material forming a family of closed-cage carbon molecules, C n , where n = 60, 70, 72, 76, 84, and even up to 100. The molecules characteristically contain 12 pentagons and a variable number of hexagons arranged in soccer ball structure (Figure 11 ). These nanomolecule with their unique structure have a great potential for variety of application and are being recently studied for biological activities relevant to biomedical applications. The fullerenes are seen as potential PDT agents as they possess some the characteristics that render them well suited as a photosensitive drug. Although pristine C 60 is highly insoluble in water and biological media and thus forms nanoaggregates, which makes it photoinactive [178] , fullerenes still have gained considerable attention as possible PDT mediators [179] after chemists have exploited this molecule by attaching the some hydophilic or amphiphilic functional groups [180] . This functionalization imparts a higher ability to produce 1 O 2 , hydroxyl radicals and superoxide anion thus making them potent PS (see Figure 11 for structures of some functionalized fullerenes used as PS).
Following are some of the advantages that these fullerenes possess over the traditional PS:
They are comparatively more photostable and are less pho-• tobleached as compared with tetrapyrroles. Fullerenes follow both type 1 and type 2 pathways. • They can be chemically modifi ed easily for tuning the • drug ' s partition coeffi cient for the variation of in vivo lipophilicity and the prediction of their distribution in a biological system. To enhance the overall ROS quantum yield, light harvest-• ing antenna can be chemically attached on C 60 [174] . Molecular self-assembly of fullerene cages into vesicles • allows multivalent drug delivery and can produce selfassembled nanoparticles that may have different tissue targeting properties.
In addition to these advantages, fullerenes demonstrate some particular disadvantages as PS for PDT. First, their extreme hydrophobicity and their innate tendency to aggregate render them even more diffi cult to formulate than other tetrapyrrole PS. Nevertheless, there has been many different strategies applied for drug delivery of fullerenes, e.g., liposomes [181 -183] , micelles [184, 185] , dendrimers [186, 187] , pegylation [188 -191] , cyclodextrin [192, 193] , and self-nanoemulsifying systems [194 -197] . Second, the main absorption of fullerenes is in the blue and green regions of the visible spectrum, rather than the red/NIR where light transmission through tissue is maximized. This unfavorable absorption could possibly be overcome by various strategies such as covalent attachment of light harvesting antennae to fullerenes [198 -202] , using optical clearing agents [203 -207] , or using two-photon PDT [208 -212] .
One potential paradox or contradiction in this fi eld is the observation that fullerenes act as antioxidants or ROS quenchers in the absence of light [213 -217] while as producers of ROS and pro-oxidants under illumination. The obvious question then arises: how then can fullerenes scavenge ROS and act as antioxidants in the dark on one hand and act as efficient producers of ROS under illumination with the correct light parameters on the other ? Andrievsky et al. [218] in 2009 fi rst proposed a way to explain this seeming contradiction. They showed that the main mechanism by which hydrated C 60 can inactivate the highly reactive ROS, hydroxyl radical, was not by covalently scavenging the radicals but rather by action of the coat of " ordered water " that was associated with the fullerene nanoparticle [219] . They also claimed that the ordered water coat could slow down or trap the hydroxyl radicals for suffi cient time for two of the radicals to react with each other, thus producing the less reactive ROS, hydrogen peroxide.
There have been many studies using fullerenes as PS to mediate PDT of both cancer cells and of pathogenic microorganisms both in vitro and in vivo [220, 221] . The fi rst study demonstrating the phototoxic effect of fullerenes was done by Tokuyama et al. [222] using carboxylic acid-functionalized fullerenes in HeLa cells. It was shown that tris-malonic acid fullerene was more phototoxic than the dendritic derivative in killing Jurkat cells when irradiated with UVA or UVB light [223] . Burlaka et al. [224] used pristine C 60 at 10 μ m with visible light from a mercury lamp to produce some phototoxicity in Ehrlich carcinoma cells or rat thymocytes. Yang et al. [225] reported three C 60 derivatives with two to four malonic acid groups (DMA C 60 , TMA C 60 , and QMA C 60 ) that were tested for their relative effi cacy in HeLa cells, and the results showed the following order of effi cacy: DMA C 60 > TMA C 60 > QMA C 60 .
There have been several studies from our laboratory using a range of functionalized fullerenes [221] . We tested a group of six functionalized fullerenes that were prepared in two groups of three compounds [173, 175] . We established that the C 60 molecule monosubstituted with a single pyrrolidinium group (BF4; Figure 11A ) was an effi cient PS that effectively killed a panel of mouse cancer cells at the low concentration of 2 μ m on exposure to white light. Chiang et al. [174] reported the synthesis of two new photoresponsive diphenylaminofl uorene nanostructures and they investigated their intramolecular photoinduced energy and electron transfer phenomena. They demonstrated that the large light-harvesting enhancement of CPAF-OMe moiety was more effi cient triplet state generator than the C 60 > cage moiety. C 60 ( > CPAF-OMe; Figure 11B ) was signifi cantly better than C 60 ( > DPAF-OMe) at lightmediated killing of human cancer cells.
The ability of cationic fullerenes for the PDI of bacteria and other pathogens has also been demonstrated in our laboratory. We were the fi rst to demonstrate that cationic watersoluble functionalized fullerenes, especially the tris-cationic compound (BF6; Figure 11C ) were effi cient antimicrobial PS and could mediate PDI of various classes of microbial cells [175] . In a study by Spesia et al. [226] , it was reported that a novel fulleropyrrolidinium iodide [DT-C 60 (2 + )] produced PDI in vitro on E. coli. Lee et al. [227] showed that C 60 derivatives were effi cient in inactivating Escherichia coli and MS-2 bacteriophage. Recently, we have demonstrated the use of innovative cationic fullerenes as broad-spectrum lightactivated antimicrobials, which was determined by quantitative structure-function relationships [228] . The most effective compound overall against the various classes of microbial cells had the hexacationic structure.
A variety of different delivery vehicles have been tested to see if the PDT effi cacy of fullerenes could be improved. Ikeda et al. [229] used a series of liposomal preparations of C 60 containing cationic or anionic lipids together. Illumination with 136-J/cm 2 350-to 500-nm light gave 85 % cell killing in the case of cationic liposomes, and apoptosis was demonstrated.
Akiyama et al. [185] solubilized unmodifi ed C 60 with high stability using various types of PEG-based block copolymer micelles, which showed cytotoxicity under photoirradiation in HeLa cells. In another study, both direct and rapid uptake (within 10 min) of fullerene into the cell membrane using an exchange reaction from a fullerene-γ -cyclodextrin complex, and the resulting photodynamic activity for a cancer cell was demonstrated [230] . Doi et al. [183] showed the PDT activity of cerasome-encapsulated C 70 in HeLa cells was similar to that of surface cross-linked liposome C 70 , indicating that C 70 can act as a PS without release from cerasome membranes. Thus, from the above in vitro studies, it was supposed that fullerenes might be suffi ciently active as PS to enable in vivo applications both for anticancer and for anti-infective use [231] .
In 1997, Tabata et al. [191] fi rst reported the use of fullerenes to carry out PDT of actual tumors. In this study, the fullerenes were chemically modifi ed to make it soluble in water as well as to enlarge its molecular size by pegylating C 60 . On intravenous injection in mice carrying a subcutaneous tumor on the back, the C 60 -PEG conjugate demonstrated a higher accumulation and more prolonged retention in the tumor tissue than in normal tissue. The volume increase of the tumor mass was suppressed and the C 60 conjugate exhibited a stronger suppressive effect than Photofrin. In another study, a novel PS was prepared from fullerene [C(60)] possessing magnetic resonance imaging (MRI) activity for effi cient PDT of tumor. This therapeutic and diagnostic hybrid system was found to be a promising tool to enhance the PDT effi cacy for tumor [190] .
Chi et al. [177] , in a preliminary in vivo study, performed PDT using hydrophilic nanospheres formed from hexa(sulfon -butyl)-C 60 (FC 4 S; Figure 11D ). Intraperitoneal administration of FC 4 S in mice had a slightly better inhibition effectiveness than the intravenous route.
We have recently shown [118] that intraperitoneal PDT with BF4 fullerene and white light has signifi cant therapeutic effects in a challenging mouse model of disseminated abdominal cancer produced by engineered bioluminescent tumor cells. Intraperitoneal injection of a preparation of N -methylpyrrolidinium-fullerene formulated in Cremophor-EL micelles followed by white-light illumination delivered through the peritoneal wall (after creation of a skin fl ap) produced a statistically signifi cant reduction in bioluminescence signal from the mouse abdomen and a survival advantage in mice. This article suggested fullerenes should continue to be explored as PS for PDT of cancer and other dreaded diseases.
In addition to in vivo anticancer applications, we have been able to translate the high degree of antimicrobial action of photoactivated fullerenes in vitro to a therapeutic effect in an in vivo infection model [176] . We used stable bioluminescent bacteria and a low-light imaging system to follow the progress of the infection noninvasively in real time in two potentially lethal mouse models of infected wounds. An excisional wound on the mouse back was contaminated with one of two bioluminescent Gram-negative species, Proteus mirabilis (2.5 × 10 7 cells) and Pseudomonas aeruginosa (5 × 10 6 cells). Fullerene-mediated PDT of mice infected with P. mirabilis led to 82 % survival compared with 8 % survival without treatment (p < 0.001). PDT of mice infected with highly virulent P. aeruginosa did not lead to survival, but when PDT was combined with a suboptimal dose of the antibiotic tobramycin (6 mg/kg for 1 day), there was a synergistic therapeutic effect with a survival of 60 % compared with a survival of 20 % with tobramycin alone (p < 0.01). The data suggested that cationic fullerenes have clinical potential as an antimicrobial PS for superfi cial infections where red light is not needed to penetrate tissue.
Carbon nanotubes and graphene
Carbon nanotubes are allotropes of carbon with a cylindrical nanostructure. Nanotubes have been constructed with lengthto-diameter ratio of up to 132,000,000:1 [232] and can be several millimeters long, signifi cantly larger than any other material. Nanotubes are categorized as single-walled nanotubes and multi-walled nanotubes. Most single-walled nanotubes have a diameter of close to 1 nm, with a tube length that can be many millions of times longer. The structure of a single-walled nanotube can be conceptualized by wrapping a one-atom-thick layer of graphite called graphene into a seamless cylinder.
Zhu et al. [233] engineered a novel molecular complex of a PS, an ssDNA aptamer, and single-walled carbon nanotubes (SWCNTs) for controllable 1 O 2 generation (Figure 12 A) . It is well known that 1 O 2 is one of the most important cytotoxic agents generated during PDT. Because the lifetime and diffusion distance of 1 O 2 is very limited, a controllable 1 O 2 generation (SOG) with high selectivity and localization would lead to more effi cient and reliable PDT and fewer side effects. First, the aptamer was developed by an in vitro process known as systematic evolution of ligands by exponential enrichment. Second, a PS was covalently attached to one end of the DNA aptamer that wrapped onto the SWCNT surface. In the absence of a target, the design becomes operational by close proximity of the PS to the SWCNT surface, which causes efficient quenching of SOG. Importantly, the conformation of the probe can be altered upon target binding. Thus, in the presence of its target, the binding between the aptamer and target molecule will disturb the DNA interaction with SWCNTs and cause the DNA to fall off the SWCNT surface, resulting in a restoration of SOG for PDT applications. An important issue with regard to PDT agents is the delivery of these molecules into the organs/tumor tissues/tissues cells. There are many strategies for drug targeting, but a satisfactory multifunctional delivery agent is nevertheless needed. SWCNTs are one distinct possibility. Erbas et al. [234] tested the use of noncovalent functionalized SWCNTs as delivery agents for Bodipy-based potential PS in PDT. The target molecule carried a solubilizing group (PEG2000), red-absorbing chromophore (distyryl-Bodipy), intersystemcrossing promoter heavy atoms (iodines at 2 and 6 positions of the Bodipy core), and two pyrene substituents on the styryl branches of the chromophore for p-stacking interactions with the SWCNTs.
Shiraki et al. [235] developed a thermo-and light-responsive system consisting of SWCNT and helical polysaccharide modifi ed with poly(NIPAM) side-chains through supramolecular polymer wrapping. Coagulation of the complex can be induced by the external stimuli, which leads to a catchand-release action of a porphyrin derivative. This method, therefore, is expected to develop a novel site selective PDT technique by dual-light irradiation using visible and NIR light sources; for example, a nondisease site close to a disease site can be protected by irradiating with NIR laser through SWCNT quenching and only the disease site was selectively decomposed by visible light irradiation.
Graphene oxide (GO) consists of sheets sp2-and sp3-hybridized carbon atoms, including carboxyl, hydroxyl, and epoxide functional groups [236] . It has gained increasing attention owing to its excellent biocompatibility, well-dispersed stability in aqueous solution, and ability of the GO sheets, which have a large specifi c surface area, to be loaded with large amounts of hydrophobic drugs [237] such as doxorubicin [238] . Zhou et al. [239] loaded GO with HA (GO-HA) as shown in Figure 12B , a perylenequinonoid hydrophobic nonporphyrin PS isolated from parasitic fungi Hypocrella bambuase found in the People ' s Republic of China [240] . The optimal loading was found to be 1 mg/mg by fl uorescence and the GO-HA had a somewhat lower 1 O 2 quantum yield compared with free HA. The stability of the GO-HA in aqueous solution was much higher than HA, and there was less dark toxicity but comparable phototoxicity toward HeLa cells. Huang et al. [241] conjugated GO with folic acid and then loaded ce6 (80 % loading). These nanocarriers delivered ce6 to MGC803 folate-receptor-positive cells, and this uptake could be blocked by free folate, suggesting a receptor-mediated process. In vitro PDT gave signifi cant killing. Tian et al. [242] loaded ce6 onto PEG-functionalized GO via π -π supramolecular stacking. They not only studied PDT killing using a 660-nm laser but also found signifi cant synergism when PDT was combined with the preadministered photothermal effect of exciting the GO with a 808-nm laser .
Miscellaneous nanoparticles
In this section, we will cover some nanoparticles that have been used for PDT and that do not conveniently fi t into our other categories.
Upconverting nanoparticles
Upconversion (UC) refers to a family of nonlinear optical processes in which the sequential absorption of two or more photons leads to the emission of light at shorter wavelength than the excitation wavelength (anti-Stokes-type emission). In contrast to other emission processes based on multiphoton absorption, UC can be effi ciently excited even at low excitation densities. There are three possible mechanisms for this to occur [243] : APTE effect (for the French " addition de photon par transferts d ' energie " ), later also named ETU for energy transfer upconversion [4, 5] excited-state absorption (ESA), and photon avalanche (PA). All three mechanisms are based on the sequential absorption of two or more photons by metastable, long-lived energy states. This sequential absorption leads to the population of a highly excited state from which UC emission occurs. In the case of ESA, the emitting species sequentially absorb at least two photons of suitable energy to reach the emitting level ( Figure 13 ). In ETU, one photon is absorbed by the ground state but subsequent energy transfer from neighboring metastable states results in the population of a highly excited state of the emitting species ( Figure 13) . The most effi cient UC mechanisms (even at room temperature) are present in solid-state materials doped with lanthanide ions. The most effi cient UC phosphor to date, Yb 3 + -and Er 3 + -doped NaYF 4 , was introduced by Menyuk et al. in 1972 [244] . The development of nanocrystal research has evoked increasing interest in the development of synthesis routes, which allow the synthesis of highly effi cient, small UC particles with narrow size distribution able to form transparent solutions in a wide range of solvents. High-quality UC nanocrystals can be routinely synthesized, and their solubility, particle size, crystallographic phase, optical properties, and shape can be controlled [243] . In recent years, these particles have been discussed as promising alternatives to organic fl uorophosphors and QD in the fi eld of medical imaging and PDT.
Chatterjee and Yong [245] designed UC NPs composed of sodium yttrium fl uoride (NaYF 4 ) nanocrystals co-doped with Yb 3 + and Er 3 + with a polymeric coat of poly(ethylenimine) (PEI). PS ZnPC was superfi cially noncovalently adsorbed to the NPs. They could image cellular uptake by fl uorescence imaging microscopy of PEI/NaYF 4 :Yb 3 + :Er 3 + NPs, and they found signifi cant cell death following irradiation with NIR laser light.
Ungun et al. [246] synthesized UCP nanocrystals by a high-temperature ligand exchange reaction that produced nanoparticles of approximately 160 nm in diameter with a hydrophobic trioctyl phosphene-oleic acid surface coating. The co-encapsulation of the UCP nanocrystals with the TPP PS and a PEG protective layer to form the complex functional nanoparticle UCPs was done in one step using a " fl ash nano-precipitation process " [247] . When these UCP-NP were excited by two 980-nm photons, they produced UC 560-nm light that excited the TPP and produced 1 O 2 as measured by bleaching of the fl uorescent dye 9,10-anthracenedipropionic acid.
Wang et al. [248] were able to show that UCP NP containing ce6 were able to kill HeLa and 4T1 cancer cells after illumination with a 980-nm laser. Furthermore, they used intratumoral injection of UCP NP into 4T1 subcutaneous tumors growing on backs of Balb/c mice followed by 980-nm laser (0.5 W/cm 2 for 30 min to give 900 J/cm 2 ). Tumors on 7 of 10 mice disappeared in 2 weeks after PDT and showed no tumor regrowth and survived over 60 days. Hematoxylin and eosin staining of tumor slices collected from UCNP-ce6 PDT treated mice at day 7 showed that most tumor cells were severely destroyed, in marked contrast to the control tumor slices where no obvious damage was found.
Simultaneous two-photon excitation nanoparticles
In contrast to UC, simultaneous two-photon excitation ( Figure  13 ) requires extremely high power densities that can only be readily achieved with femtosecond lasers. Two-photon absorption (TPA) was originally proposed by Maria G ö ppertMayer in 1931 in her doctoral dissertation [208] , but the fi rst experimental verifi cation was provided by Werner Kaiser in 1961, facilitated by the recent development of the laser, which was required for excitation because of the intrinsically low intensity of TPA. TPA is a third-order nonlinear optical process and therefore is most effi cient at very high intensities.
Long-wavelength near-IR light λ > 780 nm has relatively low photon energy ( > 1.5 eV) and is generally too low to activate most PS by one-photon excitation. Therefore, onephoton absorption fails in the phototherapeutic window 780 -950 nm, where tissues have maximum transparency to light. Sensitization by simultaneous TPA [209] combines the energy of two identical photons arriving at the PS at the same time and can provide the energy of a single photon of half the wavelength, which is suffi cient to excite the PS to the fi rst excited singlet state. It was not until the 1990s that rational design principles for the construction of two-photonabsorbing molecules began to be developed, in response to a need from imaging and data storage technologies and aided by the rapid increases in computer power that allowed quantum calculations to be made. The accurate quantum mechanical analysis of two-photon absorbance is orders of magnitude more computationally intensive than that of one-photon absorbance.
Gary-Bobo et al. [249] prepared MSN containing a porphyrin for effi cient TPA-PDT. The MSN surface was postfunctionalized with a mannose derivative to target lectins overexpressed by cancer cells [14] . Incubated with cancer cells, these MSNs were nontoxic under daylight illumination. TPE-PDT with these MSNs was investigated in vitro on human breast and colon cancer cell lines. In vivo experiments were also performed on athymic mice bearing xenografted tumors from colon cancer cells. They showed that the porphyrin was covalently encapsulated inside MSNs (6850 units of PS per nanoparticle) and having a hydrodynamic diameter of 118 nm. Grafting of the mannose moiety on the surface yielded MSN-mannose. The TPA properties of PS are retained in the MSNs with 1200 Goppert-Mayer units [GM, where 1 GM = 10(50) cm 4 s/photon/molecule] per PS. TPA-PDT was carried out at 760 nm using a confocal microscope equipped with a mode-locked Ti/sapphire laser generating 100-fs-wide pulses at a rate of 80 MHz. The laser beam was focused by a microscope objective lens (10 × , NA 0.4). The wells were irradiated at 760 nm by three successive scans of 1-s duration each at an average power of 80 mW. The surface of the scanned areas was 1.5 × 1.5 mm (mean fl uence of 10.6 J/cm 2 ). Three cancer cells lines (MCF-7, MDA-MB-231, and HCT-116) showed TPA-PDT killing with evidence of mannose receptor targeting. TPA-PDT in vivo , on nude mice bearing HCT-116 xenografts used intravenous injection with MSN1-mannose (16 mg/kg). Three hours later, tumors were submitted to two-photon irradiation at 760 nm for three periods of 3 min and light was focused on three different tumor areas. Thirty days after treatment, PDT-treated tumors showed a growth delay compared with saline controls.
Grimland et al. [250] conjugated polymer nanoparticles (CP dots) that allow effi cient intraparticle energy transfer from the conjugated polymer donor to a variety of acceptors. These nanoparticles formed from poly(2-fl uoro-1,4-phenylene vinylene) (PFPV) were conjugated to TPP and were 50 nm diameter and formed a stable colloidal suspension in water. The TPA cross section of TPP-doped PFPV nanoparticles at an excitation wavelength of 800 nm was determined using a passively mode-locked Ti/sapphire laser (800 nm, 100 fs). The particles contained 600 molecules of PFPV and 6000 molecules of TPP. The two-photon fl uorescence cross section of the TPP-doped PFPV CP dots was determined to be 5 × 10 5 GM. The 1 O 2 quantum yield in aqueous solutions was determined to be 0.5 for PFPV dots doped with TPP.
Self-illuminating nanoparticles
Chen and Zhang [139] developed an innovative class of nanoparticle for PDT that was termed " self-lighting. " It relied on the combination of conventional ionizing radiation therapy with PDT. Scintillation or persistent luminescence nanoparticles with attached PS such as porphyrins were used and upon exposure to ionizing radiation such as X-rays, the nanoparticles emitted scintillation or persistent luminescence, which, in turn, activated the PS; as a consequence, 1 O 2 was produced. Importantly, this approach could be used for deep tumor treatment as X-rays can penetrate much deeper into the tissue compared with visible light. First, absorption of the ionizing radiation (X-ray photons) creates primary electrons and holes in pairs. Next, thermalization of the low-energy secondary electrons (holes) results in a number of electron-hole pairs (excitons) with energy roughly equal to the band-gap energy Eg or electron-phonon relaxation. Energy transfer from the electron-hole pairs to the luminescence centers induces their excitation and emission from the luminescence centers occurs. High-density materials made with high-atomic-number elements will have high luminescence effi ciency. Nanoparticles constructed from BaFBr/Eu 2 + have three emission bands, peaking at around 400, 500, and 640 nm, respectively. The emission spectrum of these nanoparticles perfectly matches the absorption spectra of most porphyrins such as 5,15-diphenyl-2-3-dihydroxychlorin.
Magnetic nanoparticles
MNPs have been intensively investigated as MRI contrast agents and exhibit a unique MR contrast enhancement effect that enables noninvasive MRI of cell traffi cking, gene expression, and cancer [251] . In addition, MNPs have been recognized as a promising tool for the site-specifi c delivery of drugs and diagnostic agents by an external magnetic fi eld applied outside the body [252] . Figure 14 shows the general structure of a MNP with biocompatible coating and PS attached by a linker.
Huang et al. [253] coprecipitated FeSO 4 and FeCl 2 to form 10-nm MNP, functionalized them with amino groups using a silane, and conjugated ce6 using carbodiimide chemistry. Fluorescence microscopy showed uptake into human gastric cancer MGC803 cells, and phototoxicity was observed after 24-h incubation. MGC803 tumors grown in nude mice were imaged by both in vivo fl uorescence and MRI after intravenous injection of 0.125 μ mol ce6 eq/kg up to 8 h postinjection. In vivo PDT was carried out at 8-h time point with 632.8 nm HeNe laser, with a total light dose 5.88 J/cm 2 at an irradiance of 9.8 mW/cm 2 , and signifi cant tumor destruction was observed.
Tada et al. [254] prepared nanoparticles consisting of a silica layer over a magnetic core composed of magnetite and entrapping MB as PS. The 
Lipoprotein nanoparticles
Lipoproteins are naturally occurring nanoparticles composed of specifi c apoproteins, phospholipids, and cholesterol on the surface that encapsulate a mixture of cholesterol esters and triglycerides in the hydrophobic core [257] . The family consists of chylomicron (75 -1200 nm), very-low-density lipoprotein (30 -80 nm), low-density lipoprotein (LDL, 18 -25 nm), and high-density lipoprotein (HDL, 5 -12 nm). Such biocompatible, lipid-protein complexes are ideal for loading and delivering cancer therapeutic and diagnostic agents. By mimicking the endogenous shape and structure of lipoproteins, the nanocarrier can remain in circulation for an extended period while largely evading the reticuloendothelial cells in the body ' s defenses. The small size ( < 30 nm) of LDL and HDL allows them to maneuver deeply into tumors. Furthermore, LDL has innate cancer-targeting potential, as LDL receptors are overexpressed on malignant cells and has been used to incorporate diverse hydrophobic molecules and deliver them to tumors.
Li et al. [258] prepared a tetra-t -butyl silicon phthalocyanine bisoleate, SiPcBOA, and effi ciently incorporated it into reconstituted LDL to form r-SiPcBOA-LDL (see Figure  15 ). It was tested with HepG2 human hepatocarcinoma cells (which overexpress LDL receptors). The nanoparticles had a very high payload (SiPcBOA to LDL molar ratio, 3000 -35,001:1). Using electron microscopy, they found reconstituted LDL essentially retained the mean particle size of native LDL. As acetylated LDL binds to scavenger receptors of endothelial and microglial cells instead of LDLR, SiPcBOAreconstituted acetylated LDL, r-SiPcBOA-AcLDL, was also prepared to serve as a negative control to validate the LDL receptor LDLR-targeting specifi city. Confocal microscopy studies demonstrated that the internalization of r-SiPcBOA-LDL by HepG2 tumor cells was mediated by LDLR pathway. The in vitro PDT response of HepG2 cells to r-SiPcBOALDL was compared with SiPcBOA-free drug control using a clonogenic assay and indicated greatly enhanced effi cacy of LDLR-targeted PDT.
Marotta et al. [259] from the same group prepared an analogous molecule, bacteriochlorin e6 bisoleate and incorporated it into reconstituted LDL to form (r-Bchl-BOA-LDL).
HepG2 cells were injected into nude mice to form subcutaneous tumors. Three hours after intravenous doses of 2 μ mol/kg r-Bchl-BOA-LDL, 750-nm laser illumination was delivered at fl uences of 125, 150, or 175 J/cm 2 at a fl uence rate of 75 mW/cm 2 . The best tumor response was obtained with the 125 J/cm 2 , which also gave the least phototoxicity to normal footpad.
Actively-targeted nanoparticles
Ideally, PDT holds the promise of dual selectivity, a preferential tumor uptake of the PS and the restricted illuminated area for an improved selectivity. However, for applications of PDT in complex anatomical sites, confi ned irradiation is not possible, leading to phototoxicity to normal tissues. Moreover, several cases of prolonged skin photosensitivity after sunlight exposition have been reported [260] . Targeted drug-delivery systems are one of the strategies proposed to solve these problems underlying nonspecifi c PS accumulation. Active targeting encompasses the strategy of coupling a specifi c entity to the surface of the nanoparticle, enhancing their selective interaction with target cells recognized by specifi c markers. Although MoAbs has received the most attention, biochemical, metabolic, and physiological alterations of tumor cells offer numerous other potent targets to exploit during the delivery of PS. Targeting nanoparticles with these specifi c moieties offers several advantages. The specifi c localization increases the effi ciency and selectivity of PDT, resulting in a lower effective dose. Unlike other strategies such as ligand-PS conjugates, targeted nanoparticles can deliver thousands of molecules of PS using fewer molecules of ligands per nanoparticle, reducing considerably the cost and time-consuming synthesis of some of these targeting moieties. In addition, the presentation of multiple targeting molecules on the surface of the nanoparticle can restore multivalent binding of monovalent antibody fragments and hence increase their binding avidity for the target antigens. In this section, we will further describe some of these macromolecular moieties used to selectively address PS-containing nanoparticles to tumor tissues. Figure  16 schematically illustrates some of the targeting ligands that have been used to target PS-loaded nanoparticles.
Targeted drug delivery is a promising strategy to improve the effi cacy and safety of PS. However, a potential drawback of active targeting is related to the so-called binding site barrier phenomenon. This hypothesis considers the idea that macromolecular ligands could be prevented from penetrating tumors through their successful binding to the target receptor. Some works have reported direct experimental evidence of the binding site barrier phenomenon in various systems [261, 262] .
Monoclonal antibodies
Antibody-based drug delivery is a widely studied approach to improve the selectivity of PDT. MoAbs have the advantage over most of other tumoritropics to possess a high degree of specifi city. However, they have some drawbacks such the cost, the time-consuming production and the possible immune reactions that limit their extensive use and commercialization. The use of antibody fragments, such as F ab V and scF v molecules, is an alternative that preserves the high degree of specifi city, but the immune reactions are signifi cantly reduced [28] . Numerous published works prove the validity of the use of MoAb in a wide range of nanoparticles for selectively targeted PDT. The high epidermal growth factor (EGF) receptor expression that frequently accompanies several tumor types makes this receptor an attractive candidate for targeting strategy. Stuchinskaya et al. [263] recently published an antibody-phthalocyanine-AuNP conjugate to selectively target breast cancer cells that overexpress the HER2 EGF receptor (EGFR). Kameyama et al. [264] used the conjugation of an anti-EGFR MoAb with a verteporfi n-loaded nanoparticles. They found a threefold higher incorporation of the complex into A431 cells in vitro , and the tumor size in vivo experiments showed a signifi cant decrease compared with tumors treated with verteporfi n-nanoparticle complex without the antibody. Nevertheless, the use of MoAb for targeting therapies offers a wide range of alternatives. Rancan et al. [265] developed a fullerene hexa-adduct conjugated with the MoAb rituximab. The antibody conjugate conserved the affi nity and selectivity toward CD20-positive B-lymphocytes, whereas the antibodyfree complex did not show any intracellular uptake. T- 43 MoAb was used to demonstrate a MoAb-dependent enhancement of the uptake by a bladder tumor cell line of a pheophorbide-a liposomes [266] . In a similar approach, aluminum sulfonated phthalocyanine (liposomes linked to a targeting MoAb 791T/36 showed an in vitro antibody-dependent cytotoxicity on different cell lines expressing the target antigen [267] . MoAbs have also been attached to MNPs with a preliminary success [268] .
Aptamers
Aptamers are small, simple, and synthetic DNA or RNA oligonucleotides and represent a nonimmunogenic alternative to binding to their target proteins specifi cally [269] . Their intrinsic advantages, such as reproducible synthesis, adaptability for molecular engineering, easy manipulation, and excellent stability make the design of controllable PDT feasible [270] . Zhu et al. [233] have designed a novel PDT agent using a human α -thrombin aptamer covalently linked with ce6 and then wrapping onto the surface of an SWCNT. As SWCNTs are effi cient quenchers of 1 O 2 , the photodamage was only achieved when the binding of target thrombin disturbed the DNA interaction with the SWCNT and caused the aptamer to undergo spatial unquenching, restoring 1 O 2 generation. Stephanopoulos et al. [271] used a targeted, multivalent PDT vehicle for treatment of Jurkat leukemia T cells. Bacteriophage MS2 virus capsid was internally modifi ed with up to 180 porphyrins and the exterior with 20 copies of a Jurkat-specifi c aptamer. These capsids were able to target and selectively kill more that 76 % of cells after illumination. Despite their advantages, fewer functional aptamers have been identifi ed compared with antibodies. As an attractive alternative, special attention is given to vitamins as targeting ligands for selective PDT.
Folate ligands
Folic acid, also known as vitamin B9, is essential for the proliferation and maintenance of cells. The overexpression of folate receptor (FR) on a variety of epithelial cancer cells including cancers of ovary, lung, kidney, breast, brain, and colon [272] and the high affi nity of folate for its receptor has attracted wide attention as a targeting agent for tumor selectivity. Folate-decorated liposomes [273] , QD-folic acid conjugates [172] , pullulan/folate-PS nanogels [274] , or FR-targeted solid lipid nanoparticles [275] used the specifi c interaction with FR to assess superior cancer cell selectivity. FR cell selectivity greatly increases phototoxicity and cellular uptake compared with nonfunctionalized drug-delivery systems. Huang et al. [241] also developed the folic acid-conjugated GO as a novel targeting drug-delivery system for PDT. It was found that ce6-loaded nanocarriers can signifi cantly increase the accumulation in tumor cells and lead to a remarkable photodynamic effi cacy on MGC803 cells upon irradiation. These fi ndings suggest that folic acid has great potential as an effective drug-delivery system in targeting PDT.
Peptides
Small peptides that selectively recognize tumor cells represent an excellent approach for targeting therapies. Peptides are synthetic molecules consisting of several amino acids linked together and, in contrast to proteins, generally do not possess a well-defi ned three-dimensional structure. Their effective tissue penetration and selective binding to cancer cells make peptides ideal candidates for the delivery of therapeutic agents. Anti-angiogenesis-based research has become one of the most promising and actively explored fi elds. Recent studies from Qin [56] and Hah [276] have shown that the attachment of F3 peptide groups to the MB-conjugated polymeric nanoparticles results in effective and selective tumor cell killing. F3 has been shown to selectively target to tumor cells and angiogenic vasculature and to also have cell-penetrating properties. Reddy et al. [73] also used the surface-localized tumor vasculature targeting F3 peptide for a selective treatment and imaging of brain tumors. Treatment of glioma-bearing rats with targeted multifunctional polymeric nanoparticles showed a signifi cant improvement in survival rate compared with nontargeted nanoparticles. Rozenzhak et al. [277] demonstrated that the use of a noncovalent peptide (Pep-1) facilitated the internalization of QD. Pep-1 seems to be extremely effi cient in the targeting of proteins into cells independent of endocytosis. Oku and Ishii [278] used the APRPG peptide, specifi c for angiogenic endothelium, to modify BDP-MAcontaining liposomes. This neovessel-targeted strategy results in strong tumor destruction with a low dose of the PS.
Hyaluronic acid
Hyaluronic acid is a targeting ligand that recognizes CD44, known as the hyaluronic acid receptor, which is involved in cell adhesion and is also overexpressed on many cancer cells [279] . CD44 targeting has been used to deliver many types of anticancer agents, for instance, doxorubicin or mitomycin c encapsulated within the aqueous core of the high-molecular-weight hyaluronic-modifi ed liposomes [280] . Li et al. [281] prepared acetylated low-molecular-weight hyaluronic acid/pheophorbide a conjugate for the preparation of nanogels (Ac-HA-Pba). The nanogels observed were smaller than 200 nm in size, with a monodispersed size distribution. The nanogels displayed autophotoquenching qualities in water. The critical self-quenching concentration of the conjugates was found to have decreased as the content of Pba increased. Although Pba was conjugated with HA, the nanogel photoactivity, in terms of fl uorescent properties, 1 O 2 generation, and photocytotoxicity, was approximately maintained. Confocal imaging and fl ow cytometry analysis showed that Ac-HA-Pba nanogels were rapidly internalized into HeLa cells via an HA-induced endocytosis mechanism, a process that could be blocked with the application of an excess of HA polymer.
In vivo studies
Most PS molecules are hydrophobic and can aggregate easily in aqueous media, which can affect their photophysical properties (decrease of 1 O 2 formation), chemical properties (decrease of solubility), and biological properties (biodistribution and pharmacokinetics). Moreover, some PS that were initially considered promising in in vitro studies have never been evaluated for clinical applications, mainly because their in vivo selectivity or effectiveness was not high enough due to aggregation. Nanoparticles represent emerging PS carriers that show great promise for PDT in vivo compared with conventional PS.
Aliphatic PLA, PGA, and their copolymer PLGA are among the most studied synthetic polymers for drug delivery in vivo .
Due to its well-vascularized structure, the chorioallantoic membrane (CAM) of the developing chick embryo can act as an in vivo model to study photodynamic activity of PS-loaded nanoparticles. Vargas et al. [282] compared the effi cacy the vascular effects of p -THPP either as a free solution or encapsulated in polymeric nanoparticles in the CAM model. They showed that PDT-induced vascular occlusion of the PS p -THPP is enhanced when encapsulated into nanoparticle delivery systems. The superiority of nanoparticles over solubilized p -THPP might be related to the reduced diffusion of p -THPP nanoparticles out of the vessels. Where free p-THPP appeared to leak out before generating an effi cient vascular occlusion, nanoparticles appeared to confer a longer residence time inside the vasculature, thus inducing an increased PDT effect [282] . Recently, they investigated the main physicochemical and photochemical properties of m -THPP encapsulated in PLGA nanoparticles of different sizes via an emulsifi cation-diffusion technique. They reported that smallest size of nanoparticles (117 nm) exhibited the highest rate of ROS production and the fastest m -THPP release in the CAM model [36] . Pegaz et al. [283] compared the photodynamic activities of PS with different hydrophobicity entrapped in biodegradable nanoparticles composed of poly( d,l -lactic acid). Analysis of nanoparticles showed that the dye was more effectively entrapped in the polymeric matrix when its degree of lipophilicity increased. Meso -tetra-(4-carboxyphenyl)-porphyrin (TCPP) and ce6 were less hydrophobic than m -THPP and pheophorbidea. The nanoparticles loaded with the most lipophilic molecule ( m -THPP) induced vascular damage in the CAM model.
Dendrimers are a new class of polymeric materials with repeatedly branched molecules, recognized as the most versatile and compositionally and structurally controlled nanoscale building blocks. Their properties are dominated by the functional groups. Casas et al. [284] demonstrated a good correlation between in vitro and in vivo properties of an ALA-dendrimer conjugate that is able to induce sustained and effi cient porphyrin production. The ability of the dendrimer to enhance porphyrin synthesis was investigated in a BALB/c mouse model of subcutaneous LM3 tumors after systemic intraperitoneal administration. The ALAdendrimer induced sustained porphyrin production for over 24 h, and background values were not reached until 48 h after administration, whereas the porphyrin kinetics from ALA exhibited an early peak between 3 and 4 h in most tissues. Integrated porphyrin accumulation from the dendrimer and ALA, at equivalent molar ratios, was comparable showing that the majority of ALA residues were liberated from the dendrimer. The porphyrin kinetics appeared to be governed by the rate of enzymatic cleavage of ALA from the dendrimer.
Reddy et al. [73] have developed a multifunctional polymeric nanoparticle consisting of a surface-localized tumor vasculature and tumor-targeting F3 peptide that encapsulated Photofrin. The rats from the Photofrin group had a median survival time of 13 days, whereas animals treated with the F3-targeted Photofrin nanoparticles had a median survival of 33 days, with three animals surviving past 60 days. Moreover, Largely based on a table in the review by Meng et al. [314] . CNT, carbon nanotube; NP, nanoparticle; QD, quantum dot; UFP, ultrafi ne particle.
two of these three animals were found to be disease-free 6 months after treatment. Barth et al. [285] investigated the possibility of using nanotechnology enabled PDT to treat leukemia, a form of blood cancer not generally treated with PDT. Indocyanine green (ICG), which is a highly fl uorescent NIR dye that can also act as a PS, was loaded into nontoxic and nonaggregating calcium phosphosilicate nanoparticles (CPSNP). Citrate-functionalized CPSNP were activated by 1-ethyl-3 -(3-dimethylaminopropyl)-carbodiimide and then reacted with sulfo-NHS to form a high-yield, semistable intermediate. The sulfo-NHS ester-containing CPSNP were then reacted with heterobifunctional PEG containing both amine and carboxyl functional groups. This synthetic process was repeated with the carboxyl-PEG functional terminals of the pegylated CPSNP to generate sulfo-NHS ester-containing pegylated CPSNP, which readily reacted with antibodies that recognize CD117 or CD96, surface features enhanced on leukemia stem cells. Cell-specifi c PDT killing was observed in in vitro studies with 32D-p210-GFP murine leukemia stem cells and with CD34 + CD38-CD96 + cells from an acute myeloid leukemia patient. An in vivo study used intravenous injection of 32D-p210-GFP into C3H/HeJ mice to establish myeloid leukemia. The targeted ICG-CPSNP was intravenously injected (0.1 ml of 200 n m ICG equivalent concentration) followed within 30 min by 12.5 J/cm 2 of 810-nm laser directed to the surgically exposed spleen. When the treatment was repeated every 3 days, a 29 % disease-free survival was obtained.
Nanotoxicology
The recent emergence of widespread biomedical and industrial applications of nanotechnology has given rise to a whole new area of nanotoxicology [286, 287] . This discipline is based on the widely held assumption that materials, which are largely harmless on the normal macroscopic scale, can exhibit completely different biological properties on the nanoscopic scale and that undiscovered harmful effects both on people and on the environment may pose threats to health. There is even a new journal titled Nanotoxicology . Nanoparticles have much larger surface area to unit mass ratios, which in some cases may lead to greater proinfl ammatory effects (for example, in lung tissue) [288] . In addition, some nanoparticles seem to be able to translocate from their site of deposition to distant sites such as the blood and the brain [289] . Nanoparticle toxicologists study the brain, blood, liver, skin, and gut in addition to the traditional concentration on lung toxicity. Table 1 shows a selection of recent reports concerning nanotoxicology both in vitro and in vivo based on a table in a review by Meng et al. [314] . Nanotoxicity can be caused through inhalation, ingestion, skin uptake, and injection of engineered NPs. Importantly, NPS toxicity depends on multiple factors derived from both individual NPs physicochemical properties and environmental conditions: NPs size, charge, concentration, outer coating bioactivity (capping material, functional groups), and oxidative, photolytic, and mechanical stability have each been shown to be determining factors in NPs toxicity [315] . The greater surface area per mass compared with larger-sized particles of the same chemistry renders NP more active biologically. In addition, the internalization of NP was highly dependent on size, with the most effi cient uptake occurring within the 25-to 50-nm size range [316] . Ultrafi ne particles (UFP) are defi ned as a size < 100 nm NPs, which has most active bioactivity. This activity includes a potential for infl ammatory and pro-oxidant effects but can also exhibit antioxidant activity.
It has long been known that asbestosis fi bers cause asbestosis and mesothelioma when inhaled, and several authors have asked whether SWCNT (which have similar characteristics to asbestosis fi bers) can have similar adverse effects [317 -319] . Reports that fullerenes exhibited toxicity toward various fi sh [320, 321] have been discounted by other authors [322] and attributed to the presence of a tetrahydrofuran bioproduct introduced during fullerene preparation [323] .
The other important area of nanotoxicology has been that of QD. The possible use of materials such as CdSe [324] and cadmium telluride (CdTe) [325] in QD construction has led to concerns about heavy metal toxicity, which would preclude any clinical use. These studies concluded that QD could cause indirect in vivo genetic damage, which may be attributed to free radical-induced oxidative stress in mice.
Conclusion
At the end of this review, it is necessary for the authors to address the question that we originally posed, " can nanotechnology potentiate PDT ? " The answer in some areas is an unequivocal " yes, " but in other areas, the jury is still out. One of the areas where nanotechnology has made huge improvements is in the use of different drug-delivery vehicles for PS, particularly in the use of liposomes [326] . The enormous clinical success of Visudyne (total sales of several billion $) have made it an important member of the list of approved liposomal drugs [327] . Liposomal Visudyne has also widened the acceptance of preformulated drug-delivery vehicles in the PDT fi eld.
In many of the articles covered in the previous sections of the present review, the authors have compared their particular nanoparticle formulated PS with the identical PS delivered in its free form. In some cases, major improvements in cell uptake, tumor localization, and PDT response were observed for the nanoparticle formulation. Some of these reports, however, use PSs that are not particularly effective in their free form so that nanoformulated preparations automatically appear better. Such criticisms could be made in the case of, for example, ce6 and PPIX. These PS are known to be only moderately effective in their free unformulated form. Other PSs, for example, Foscan ( m -THPC) are so effective in their free state that encapsulating them into nanoparticles is likely to only reduce their effectiveness. Of course, it could then be argued that improved pharmacokinetics, better tumor targeting, or lower normal tissue phototoxicity would be a desirable consequence of reducing their overall excessive PDT activity, which could otherwise damage normal tissue.
Lessons learned from past drug-delivery problems in PDT will only underscore the necessity of using appropriate well-defi ned and well-characterized nanoparticle vehicles in the future. It is hoped that these nanocarriers will improve the phamacokinetics, serum stability, biodistribution, tumor targeting, and photophysics of many PS. The pronounced tendency of most PS to undergo self-aggregation is due to the inherent electron-delocalized planar structures needed to have a high visible absorption [328] .
When this structural attribute is combined with an overall hydrophobic substitution pattern, it is not surprising that insolubility and aggregation in water is a big problem. The ability of these PS to satisfactorily dissolve in the hydrophobic domains of lipid bilayers of liposomes [3] or the interior of detergent micelles is responsible for the dramatically improved performance of PDT mediated by these delivery vehicles.
There has recently been an explosion of interest in the area of " theranostics " [329] . This area can be defi ned as the combination of diagnostic, imaging, and therapeutic agents on the same platform [330] . These combination agent platforms frequently take the form of multifunctional nanoparticles [331, 332] . For the detection/imaging functionality, it is possible to use one or more from the following list [333] : fl uorescence imaging (based on attached fl uorophores), photoacoustic imaging (based on intrinsic or attached absorbers), SERS (based on intrinsic gold or silver), MRI (based on attached paramagnetic relaxation agents), positron emission tomography (PET, based on attached PET isotopes), singlephoton emission computed tomography (based on attached γ -emitting isotopes). Although the therapeutic functionality can take the form of attached cytotoxic drugs that are released from the nanoparticle [330] or therapeutic radioisotopes [334] , many groups have constructed a light-activated modality into their multifunctional nanoparticle that is either photothermal or photodynamic (or even both at the same time). This property of multifunctionality is one of the areas where the concepts of nanotechnology will be critical in further progress.
The use of active targeting moieties to direct PS-loaded nanoparticles to tumors or other biological targets is another rapidly growing area where nanotechnology may provide a distinct advantage over traditional conjugation methodology. If the targeting ligand (antibody, peptide, folate, aptamer, etc.) is attached directly to the PS, the number of PS that can be delivered to each tumor cell is limited. Note that a typical number of receptors per tumor cell is about 100,000, and the number of PS needed to kill a cancer cell could be as high as 10 7 . Therefore, each receptor might need to deliver as many as 100 PS molecules, and the best method of ensuring this ratio is to attach the targeting ligand to a nanoparticle loaded with PS.
The rapid growth in nanotechnology we have seen in the last decade is only going to further continue in the coming years, and we expect that the applications of nanotechnology to potentiate PDT will also continue to grow and become ever more convincing. 
